rfhg_121167.1

Basic information about the TSS

---

TSS ID: rfhg_121167.1 Species: human Chr: chr9		Start: 136118590 End: 136118613 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC111053:0 GeneID: 90120 HGNC/MGI_ID: HGNC:31009 UniProt_ID: Nearer transcript ids and distances: ENST00000557985.2:56 BC092490:56 ENST00000448040.2:152 NM_001256526.2:152 ENST00000561457.2:159 BC014304:-169 BC013282:-211 AK023162:-226 AK091349:-231 BC021231:-250 ENST00000418388.6:-262 NM_152833.3:-262 NR_134506.2:-262 ENST00000447934.1:316 view more...

Gene_name: transmembrane protein 250 Gene_symbol: TMEM250 Gene_synonyms: bA83N9.1 Gene_source: HGNC:31009

TATA-Box annotation

---

Distance to TSS:	-170
Nearest PromoterID:	NM_001256526
Entrez ID:	90120
Nearest Unigene:	Hs.287411
Nearest Refseq:	NM_152833
Nearest Ensembl:	ENSG00000238227
Gene Name:	transmembrane protein 250
Gene Alias:	C9orf69
Gene Type:	protein-coding
CpG%:	0.086957
GC%:	0.791667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TMEM250 p2@TMEM250 p3@TMEM250 p4@TMEM250 p5@TMEM250 p6@TMEM250
Sample		p1@TMEM250	p2@TMEM250	p3@TMEM250	p4@TMEM250	p5@TMEM250	p6@TMEM250
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	23.77	6.04	2.53	1.95	1.95	3.31
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	21.24	6.07	4.05	3.03	3.03	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	22.18	2.89	2.70	2.31	1.54	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	23.91	4.16	3.33	1.87	3.33	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	26.77	4.50	1.57	2.47	2.25	3.15
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	20.74	5.43	1.94	3.29	2.33	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	26.15	3.27	2.40	3.49	3.05	2.18
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	20.59	3.39	1.21	1.70	2.18	3.15
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	25.86	4.92	2.99	1.50	3.42	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.23	1.74	1.16	5.80	2.90	3.48
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	14.96	3.23	2.43	4.85	4.45	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.39	2.03	1.63	6.50	4.07	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	13.70	6.29	5.80	1.77	2.74	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	9.77	3.61	2.86	2.26	2.26	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.44	5.49	6.15	1.76	2.20	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.05	2.77	2.51	2.26	1.26	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.95	3.49	2.18	3.71	0.66	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	15.19	3.80	3.80	2.95	1.69	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	9.06	3.73	3.73	2.67	1.07	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.93	3.91	4.81	1.35	0.75	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.30	3.88	4.14	1.87	1.47	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.84	3.80	4.14	1.55	1.73	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.05	3.36	2.97	2.84	1.55	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.46	3.64	2.67	3.40	2.18	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	8.51	4.90	4.90	1.29	1.55	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.76	5.38	2.53	1.90	1.58	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	11.54	1.65	2.20	1.10	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.79	4.72	4.48	1.18	2.83	2.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.01	4.52	3.72	2.26	1.78	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.60	3.80	3.44	2.17	0.54	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.91	2.72	3.35	1.88	1.26	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.99	3.13	2.93	1.95	1.37	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.29	1.90	3.38	2.53	1.48	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.43	1.15	1.32	0.49	0.99	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	7.85	3.74	3.37	1.50	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.62	4.22	3.64	1.92	2.30	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.18	2.66	3.27	1.43	1.43	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.47	2.82	4.43	1.01	1.61	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.02	3.24	4.59	2.70	1.08	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.88	3.84	3.84	2.64	0.72	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.06	3.06	3.29	1.65	1.18	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	6.29	2.78	1.46	0.44	0.59	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.13	3.59	4.01	1.48	1.27	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.29	3.15	3.85	1.40	1.57	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	13.25	3.61	4.02	1.81	1.81	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	17.91	3.49	5.58	2.09	1.16	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.71	4.32	7.20	1.92	1.20	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.60	3.28	4.17	1.79	1.19	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	16.76	5.27	4.79	1.91	2.39	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.00	5.05	3.64	0.81	0.81	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.48	3.69	4.30	1.43	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	14.23	3.11	3.56	0.89	1.33	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.94	2.13	1.42	0.71	1.77	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.61	4.64	2.98	0.66	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	0.84	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	4.59	0.92	1.38	0.00	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.91	4.86	2.27	0.32	1.30	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.24	3.85	2.89	1.61	0.32	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.23	3.14	0.31	0.63	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	15.51	0.71	2.82	1.41	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.17	5.05	4.49	1.12	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	10.35	0.80	1.59	0.80	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.47	1.70	1.02	0.34	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	16.57	2.92	2.92	1.30	1.62	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	14.91	4.97	3.55	0.71	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	1.46	1.46	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.42	1.49	2.48	0.99	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	11.26	1.41	4.22	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	8.61	1.99	1.99	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.81	2.78	2.78	0.93	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.42	2.45	3.67	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	13.15	3.17	3.64	0.48	0.95	0.00
Adipocyte - breast, donor2	11327-117E4	13.32	4.17	3.37	0.64	1.12	0.16
Adipocyte - omental, donor1	11473-119C6	16.16	2.54	3.69	0.89	0.76	0.13
Adipocyte - omental, donor2	11474-119C7	17.94	2.99	1.49	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	12.06	2.01	3.35	0.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	16.59	1.91	5.74	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	1.10	3.30	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	13.10	2.26	4.97	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	9.56	2.95	2.61	1.22	0.52	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	17.01	6.65	2.54	0.98	0.98	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	9.01	2.57	4.12	1.29	0.77	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	13.10	3.90	2.23	0.56	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	19.99	4.70	2.94	0.59	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	12.31	5.15	3.78	1.05	0.97	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	8.39	1.61	1.94	0.00	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	1.60	2.67	1.60	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	15.02	2.23	4.45	0.00	0.56	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	10.40	3.33	2.91	0.42	1.66	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	10.30	3.01	3.52	0.25	0.50	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	13.09	2.62	3.60	0.65	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	8.53	1.83	1.22	0.30	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	12.15	5.75	3.98	1.55	1.55	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	18.65	7.17	5.02	2.15	1.43	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	4.79	3.59	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	15.11	2.52	2.70	0.36	0.90	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	3.35	6.69	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	13.76	4.11	1.44	0.41	0.62	1.03
Anulus Pulposus Cell, donor1	11248-116E6	4.81	1.49	2.40	0.57	1.14	0.11
Anulus Pulposus Cell, donor2	11463-119B5	4.65	1.71	1.96	0.49	0.24	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.23	1.80	3.15	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	10.85	2.60	1.30	1.30	1.74	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	2.14	4.28	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.67	2.39	3.29	0.90	0.90	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	0.00	3.79	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.30	0.66	3.96	2.64	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.40	0.97	3.57	0.97	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.22	1.46	1.46	0.97	1.46	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.13	0.00	3.56	1.78	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.30	2.26	1.88	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	1.45	3.63	0.73	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	1.25	2.51	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.42	2.64	2.31	0.49	0.16	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	1.36	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.99	2.71	1.51	1.21	1.21	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.43	1.61	2.14	1.61	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.80	1.89	3.97	0.57	0.57	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.02	1.60	4.01	0.80	0.53	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	2.93	2.93	1.95	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.14	3.81	2.99	0.83	0.66	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	1.20	1.20	0.00	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.23	2.06	3.26	0.34	1.37	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	8.74	1.94	1.94	0.00	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.59	2.28	5.69	0.76	1.14	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	0.00	6.06	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.26	2.85	2.85	0.57	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.91	3.21	2.78	1.07	1.28	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.48	2.58	2.32	0.52	1.29	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.51	4.69	1.88	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.68	2.25	3.22	0.96	1.61	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	1.43	2.14	0.00	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.19	0.58	2.92	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.03	2.71	3.01	1.81	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	8.32	4.75	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	10.68	3.05	1.53	0.51	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	10.70	2.55	2.04	0.25	1.53	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.72	3.18	2.54	0.64	1.27	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.90	1.73	3.88	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.35	2.54	2.54	0.64	0.64	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.67	1.16	2.90	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	0.00	2.83	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.44	1.70	2.37	0.51	1.02	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	0.00	6.34	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.22	1.29	1.93	1.07	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	9.63	2.41	3.61	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	2.19	2.19	0.73	0.00	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.13	2.99	3.45	0.23	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	2.55	2.55	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.32	1.02	1.78	0.51	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.43	2.89	2.27	0.21	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.65	1.84	2.14	1.53	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5.26	1.43	3.35	0.48	0.96	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.31	3.33	4.66	0.22	1.55	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	3.05	0.00	0.00	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.65	1.11	2.22	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.41	2.65	4.24	1.06	1.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.72	4.36	1.09	0.00	1.09	0.36
Astrocyte - cerebellum, donor1	11500-119F6	13.88	1.11	3.07	1.35	1.11	0.49
Astrocyte - cerebellum, donor2	11580-120F5	14.55	2.74	3.94	1.03	2.23	0.68
Astrocyte - cerebellum, donor3	11661-122F5	13.00	2.73	2.94	1.05	1.26	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	8.37	2.44	2.09	1.39	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	11.00	4.04	2.26	0.81	0.97	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	11.34	3.43	2.24	1.34	0.89	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	4.24	2.06	1.95	0.57	0.69	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	4.38	3.26	1.50	1.13	0.50	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	3.98	2.50	1.48	0.91	0.68	0.34
Basophils, donor1	12241-129G9	1.57	0.78	0.52	0.26	0.00	0.00
Basophils, donor2	12242-129H1	1.80	0.00	0.00	0.00	0.36	0.00
Basophils, donor3	12243-129H2	1.62	1.76	1.03	0.00	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	14.45	4.53	2.59	0.43	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	25.15	8.23	7.31	1.83	4.11	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	20.08	8.16	5.02	3.14	1.88	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	12.27	6.03	3.74	1.87	1.25	1.46
Bronchial Epithelial Cell, donor6	11461-119B3	9.90	2.99	2.30	0.69	1.84	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	11.88	2.52	1.08	0.54	0.54	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4.53	1.24	0.82	4.43	1.13	4.02
Burkitt's lymphoma cell line:RAJI	10476-106I8	5.36	2.56	1.16	4.43	0.47	3.49
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	3.20	1.60	2.56	5.76	0.96	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	1.69	1.13	1.69	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	0.93	1.48	1.11	0.00	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	1.32	1.54	0.88	0.00	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	9.34	3.40	4.53	0.57	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.61	4.17	5.31	0.76	1.14	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	11.18	5.59	11.83	1.64	2.30	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	9.25	6.79	5.64	0.14	1.30	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	5.73	2.41	1.21	0.00	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	7.34	5.45	3.55	0.24	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.02	1.51	0.67	0.17	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1.10	1.38	0.55	0.55	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.48	1.49	0.74	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.50	0.98	1.17	0.39	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.38	1.60	0.71	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.96	1.09	1.09	0.00	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.23	0.47	0.47	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.53	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	0.00	0.00	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.65	2.53	1.49	0.45	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.79	1.20	0.80	0.20	1.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.96	1.04	1.46	0.21	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1.83	0.46	0.46	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.90	0.00	0.45	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.87	2.18	0.87	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	9.68	1.34	2.15	0.00	0.00	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	6.63	2.62	1.57	0.52	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	4.63	2.52	2.52	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.18	0.92	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.35	0.35	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.32	0.44	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.44	1.22	0.87	0.17	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.09	1.86	1.49	0.37	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	3.23	1.29	0.43	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	0.82	0.82	0.41	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.46	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.46	0.00	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	4.58	3.27	1.53	0.22	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	4.62	4.16	2.31	0.00	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	1.73	3.03	2.60	0.43	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	3.74	2.49	5.29	0.00	0.78	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	2.97	2.10	4.02	0.35	1.22	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	2.90	2.01	2.68	0.22	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	5.61	3.06	4.08	0.26	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	5.49	3.51	2.63	0.00	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	5.26	2.74	1.89	0.21	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	2.03	2.03	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4.75	4.07	3.39	3.39	4.07	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	2.07	2.07	2.07	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	3.20	3.20	2.67	0.00	2.13	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	4.29	1.07	2.68	1.07	0.54	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4.21	2.81	0.00	2.11	0.00	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1.57	0.00	3.14	0.78	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2.64	2.64	1.32	1.32	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	4.11	0.82	0.00	0.00	1.64	1.64
CD19+ B Cells, donor2	11624-122B4	0.00	0.00	0.00	1.45	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	0.00	0.00	0.50	1.01	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	11.31	1.21	1.62	0.00	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	10.79	3.60	2.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.00	0.00	0.00	0.00	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	6.76	3.01	2.25	1.50	2.25	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	5.86	2.25	3.38	4.51	1.13	1.58
CD4+ T Cells, donor1	11225-116C1	2.86	1.43	0.71	0.00	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	4.29	1.22	0.61	0.00	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	6.40	1.52	0.61	1.22	1.22	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	22.72	4.85	3.83	1.79	0.51	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	25.60	7.64	4.49	2.92	0.45	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	21.85	10.06	3.45	2.01	0.86	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	8.06	1.42	1.42	0.47	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	5.62	1.40	1.40	0.00	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	3.30	3.30	0.00	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	11.71	3.61	3.03	1.45	0.87	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	23.89	14.40	6.95	1.86	1.86	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	18.86	7.74	4.35	1.93	1.13	1.77
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.07	1.79	1.34	0.90	1.34	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	6.29	1.75	2.10	1.05	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	4.40	2.64	0.88	0.00	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	12.65	2.53	4.64	1.26	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	16.62	4.99	2.70	1.25	0.00	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	17.04	5.68	5.01	1.34	1.34	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	8.70	2.72	2.45	1.36	0.82	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	10.18	3.75	1.07	2.14	2.14	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	12.55	5.38	3.59	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	17.43	5.56	5.38	0.74	2.23	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	21.01	8.23	6.72	1.95	1.52	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.22	7.36	4.20	0.84	1.05	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	8.09	5.06	2.02	0.00	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	4.33	3.90	3.03	1.30	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	6.10	3.92	2.18	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	14.35	1.98	7.42	0.99	1.98	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	12.92	8.31	4.62	2.77	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	11.17	5.58	2.79	4.19	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	14.95	4.43	3.05	0.55	1.38	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	19.63	2.94	3.93	0.98	0.74	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	12.32	4.62	7.70	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	13.25	6.80	4.66	1.07	2.51	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	16.62	5.54	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	5.57	0.98	1.31	0.65	0.65	0.33
CD8+ T Cells, donor2	11307-117C2	3.00	0.38	0.38	0.38	1.13	0.00
CD8+ T Cells, donor3	11383-118B6	4.80	2.78	0.25	1.01	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.70	2.98	3.21	2.52	1.61	2.29
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8.15	1.20	3.12	1.20	0.72	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	15.32	1.64	3.56	0.55	0.27	2.46
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.00	1.80	3.00	0.30	1.80	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	11.76	1.68	2.88	2.64	0.48	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	12.96	2.50	3.18	1.59	1.36	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.21	1.96	2.61	0.65	0.22	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	6.84	2.63	2.90	1.84	1.58	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.49	2.81	2.11	0.70	1.41	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8.75	3.62	2.11	0.91	1.21	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.91	1.74	2.61	0.29	1.16	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	12.79	1.87	4.26	0.27	1.07	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	12.69	2.19	2.19	0.00	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.47	0.91	1.82	0.00	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	7.46	3.73	2.98	0.00	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	14.41	3.60	3.24	3.24	1.44	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	15.82	2.59	1.73	0.86	1.73	2.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	13.43	2.12	5.42	2.12	0.47	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	8.56	2.54	1.58	0.32	0.32	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.92	1.54	3.69	1.23	0.62	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	7.69	1.60	3.53	1.60	1.28	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	11.47	2.29	2.29	2.29	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.43	2.36	2.76	0.39	1.97	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.86	1.51	1.51	0.76	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.04	0.00	4.82	1.61	0.00	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	12.59	0.70	4.20	0.70	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	9.02	1.00	1.00	0.00	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	10.97	0.00	1.83	0.00	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	10.38	2.47	1.98	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	7.47	4.74	2.10	0.95	1.16	0.32
Chondrocyte - de diff, donor1	11261-116G1	14.56	4.51	4.51	1.39	1.04	0.35
Chondrocyte - de diff, donor2	11338-117F6	13.86	1.78	3.55	0.36	1.42	0.00
Chondrocyte - de diff, donor3	11410-118E6	10.58	4.32	3.53	0.68	0.46	0.57
Chondrocyte - re diff, donor2	11339-117F7	7.16	0.00	1.79	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	9.71	4.04	0.40	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	7.23	2.41	2.18	1.15	1.72	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	8.76	1.71	2.14	0.86	1.50	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	10.27	4.16	2.21	1.68	1.33	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	12.38	2.11	6.14	1.93	5.04	0.73
Corneal Epithelial Cells, donor1	11526-119I5	11.20	4.61	3.29	0.44	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	11.38	7.96	3.41	0.00	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.50	2.81	3.07	0.00	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	4.79	2.31	7.43	0.99	1.32	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	4.73	0.95	8.83	0.00	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	4.10	2.05	5.29	0.00	1.19	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1.71	1.02	0.34	0.34	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1.31	0.65	0.00	1.31	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.48	0.00	0.00	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	8.00	4.34	3.84	1.00	1.33	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	17.02	8.80	7.04	1.17	1.76	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	12.16	7.64	6.50	1.41	2.83	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	9.83	5.90	6.68	1.18	0.79	0.39
Endothelial Cells - Artery, donor1	11264-116G4	10.47	6.11	6.40	0.58	2.62	0.87
Endothelial Cells - Artery, donor2	11341-117F9	13.41	6.35	4.71	1.88	2.12	0.24
Endothelial Cells - Artery, donor3	11413-118E9	10.34	4.73	2.80	1.58	1.75	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	12.41	5.32	3.32	0.22	1.33	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	11.56	5.17	2.74	0.00	1.22	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	8.74	1.69	2.82	0.56	0.85	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	13.67	3.57	3.57	2.38	1.78	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	5.21	2.08	3.12	1.04	1.04	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	9.22	5.81	4.11	1.84	3.26	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	11.20	4.00	6.00	2.80	1.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	16.25	3.67	3.67	2.62	2.10	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	7.83	3.23	4.85	0.87	1.99	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	11.30	5.21	3.91	0.43	0.87	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	10.99	5.13	4.52	0.98	2.08	0.24
Endothelial Cells - Vein, donor1	11267-116G7	6.83	13.65	1.14	1.14	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	16.07	5.59	5.59	2.79	2.10	0.70
Endothelial Cells - Vein, donor3	11416-118F3	13.03	7.69	6.75	2.04	2.98	1.10
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	10.51	3.66	2.20	0.24	0.98	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	2.08	4.16	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.03	2.46	2.87	1.23	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.79	2.63	2.85	0.88	1.09	1.09
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.49	5.42	3.03	1.19	1.30	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	10.43	3.40	3.40	0.85	0.73	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	5.87	2.05	1.64	0.14	0.41	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	14.13	5.38	4.11	1.79	0.95	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	8.17	2.37	1.05	1.32	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.95	4.98	3.65	1.33	0.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	16.78	6.35	2.27	2.27	1.36	1.81
Fibroblast - Cardiac, donor2	11345-117G4	12.13	5.31	1.52	0.00	1.52	0.76
Fibroblast - Cardiac, donor3	11417-118F4	13.72	7.41	3.31	0.95	0.79	0.79
Fibroblast - Cardiac, donor4	11452-119A3	9.40	4.85	3.64	0.61	1.21	0.91
Fibroblast - Cardiac, donor5	11456-119A7	9.39	3.81	2.41	1.02	1.27	0.13
Fibroblast - Cardiac, donor6	11460-119B2	9.55	3.18	1.82	0.00	1.82	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	7.77	2.28	1.47	0.54	0.94	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.49	1.29	3.02	2.16	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	8.79	1.46	1.46	1.46	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	11.99	3.46	5.77	1.85	4.15	1.61
Fibroblast - Conjunctival, donor3	11692-122I9	10.18	2.04	2.54	0.68	1.53	0.17
Fibroblast - Dermal, donor1	11269-116G9	7.04	4.46	2.82	1.88	0.94	0.94
Fibroblast - Dermal, donor2	11346-117G5	11.79	5.19	4.72	1.42	2.83	0.47
Fibroblast - Dermal, donor3	11418-118F5	11.48	3.87	6.29	0.60	0.85	0.73
Fibroblast - Dermal, donor4	11450-119A1	6.33	2.03	2.94	0.57	0.68	0.23
Fibroblast - Dermal, donor5	11454-119A5	7.33	2.09	4.36	0.52	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	9.58	2.76	4.71	0.49	1.79	0.65
Fibroblast - Gingival, donor1	11237-116D4	5.83	1.04	1.87	0.42	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	10.74	5.24	4.98	0.79	1.31	0.52
Fibroblast - Gingival, donor2	11318-117D4	9.09	2.64	3.69	0.53	0.40	0.26
Fibroblast - Gingival, donor3	11394-118C8	7.64	4.83	3.09	0.68	0.77	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	11.43	3.12	1.04	0.00	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	11.81	3.35	2.82	0.18	0.88	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	7.33	2.34	3.43	0.62	0.62	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	7.98	1.89	3.52	0.14	0.54	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	22.23	5.29	8.82	1.06	2.82	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	9.51	1.75	3.95	0.44	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	9.54	1.23	2.45	0.27	0.41	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	11.74	3.18	5.16	0.66	0.88	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	8.66	3.82	4.26	0.15	2.05	0.29
Fibroblast - Lung, donor1	11270-116H1	9.52	0.00	2.72	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	7.46	2.98	4.48	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	12.03	3.17	9.92	1.27	1.06	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	15.83	1.67	4.17	0.83	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.28	5.04	4.20	0.84	0.00	0.84
Fibroblast - Mammary, donor1	11540-120B1	17.05	5.28	6.50	1.62	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	19.97	3.99	7.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	6.79	0.78	2.72	0.39	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	8.65	2.73	4.70	0.61	1.37	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	5.81	1.53	1.84	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	9.54	2.67	3.05	0.38	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.69	3.51	4.32	0.27	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	14.73	4.06	3.60	0.35	0.81	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7.18	3.32	3.98	0.99	0.66	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13.82	2.44	4.06	0.41	1.22	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.69	2.00	5.35	0.00	0.67	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	5.54	3.56	2.77	0.00	1.98	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	7.74	0.99	1.39	0.40	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.24	1.07	2.13	0.00	0.71	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	12.02	3.55	0.99	0.99	0.20	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	9.63	1.50	1.20	0.00	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	8.42	2.70	3.02	0.54	0.54	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	5.82	1.27	1.52	0.25	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	13.45	3.94	3.77	0.98	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	7.22	2.41	1.80	0.40	0.60	0.20
Fibroblast - skin normal, donor2	11561-120D4	10.85	1.81	1.81	0.20	0.50	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	6.65	3.93	2.72	0.30	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.85	1.74	3.23	0.50	0.58	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	7.69	1.20	2.22	0.34	0.51	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	10.18	1.31	0.33	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	10.87	1.17	2.34	0.53	0.53	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	8.43	3.37	5.57	1.01	0.84	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	5.18	1.73	1.57	0.31	0.63	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	3.49	1.74	1.74	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.01	2.25	1.73	1.56	0.69	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	11.19	4.94	2.08	0.26	1.56	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.18	4.34	1.28	0.51	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	14.55	3.06	2.30	16.08	4.59	6.12
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	12.76	2.55	0.00	9.57	4.47	11.49
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	28.53	4.56	1.14	4.85	2.00	3.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	36.12	3.03	2.21	9.10	3.03	13.24
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	19.41	3.88	1.83	10.73	2.97	8.45
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	25.56	4.76	2.38	7.93	2.18	10.70
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	26.70	5.82	1.32	11.63	3.17	11.10
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	17.94	2.61	1.96	13.05	2.28	9.46
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	25.21	0.44	1.77	5.31	0.44	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	17.95	2.97	1.13	3.67	2.69	4.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	15.76	3.32	0.74	4.19	2.09	2.22
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	18.54	4.03	0.27	2.69	2.15	3.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	19.33	2.60	0.74	3.35	1.86	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	18.00	3.74	0.83	3.46	2.35	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.04	2.64	0.61	4.68	1.42	3.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.17	3.42	1.37	2.51	0.91	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	15.32	3.36	0.75	3.24	1.37	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	13.99	2.84	0.66	1.75	2.62	2.62
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	20.68	3.25	1.48	2.95	2.36	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	16.69	3.34	0.79	2.38	3.02	1.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.75	3.57	2.46	2.23	1.12	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	14.72	2.62	2.02	2.02	1.21	2.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	15.95	2.37	2.21	2.88	2.21	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	15.52	2.57	1.77	3.01	1.95	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.82	2.81	2.60	2.50	2.39	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.66	2.56	1.88	1.71	2.39	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	14.61	3.54	1.99	3.10	1.55	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	14.48	2.16	1.50	1.41	1.58	1.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.88	1.63	1.02	1.63	2.04	2.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	12.17	3.51	1.03	2.89	1.86	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	13.95	1.96	2.08	1.61	2.19	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	13.17	3.34	1.50	1.33	1.50	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	13.23	3.31	2.20	1.54	2.65	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	15.13	2.58	1.84	0.98	1.35	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	15.89	3.40	2.27	1.62	1.95	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	10.90	1.92	2.25	1.92	0.64	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	12.60	3.13	1.52	1.04	0.95	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.39	4.75	2.53	2.21	2.21	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	12.77	2.74	2.43	1.22	2.43	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	12.34	3.03	1.99	1.36	1.15	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	13.61	2.42	3.51	1.98	1.54	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	10.38	3.09	2.81	1.68	1.40	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	9.63	4.26	2.41	1.02	1.48	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	13.64	1.87	2.94	0.00	2.41	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	10.71	5.51	5.05	1.99	1.68	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	10.62	4.15	3.37	0.65	1.55	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.39	3.80	1.90	0.27	1.08	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	8.48	4.06	3.50	2.03	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	10.31	3.73	2.41	0.44	2.41	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	6.94	5.95	2.98	0.00	1.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	9.63	3.30	2.90	0.53	1.45	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	8.27	3.23	3.23	1.01	1.61	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	10.17	2.03	2.03	0.76	2.54	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	10.15	0.60	0.20	2.99	1.79	2.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	12.17	1.08	0.31	4.93	1.08	2.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	22.50	3.68	0.82	6.34	0.82	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	18.78	2.19	1.25	10.01	4.07	6.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	20.06	1.98	0.57	8.48	3.11	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	14.76	0.46	0.46	8.76	0.92	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	4.95	0.00	14.85	0.00	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	16.63	3.87	0.77	6.96	1.55	5.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	3.21	0.00	3.21	6.42	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	3.48	1.74	12.17	1.74	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	15.30	1.95	0.65	4.56	1.95	4.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	14.82	2.06	0.41	4.12	1.65	3.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	6.66	0.00	6.66	0.00	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	11.47	1.96	1.68	4.19	2.24	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	15.03	1.96	0.65	4.90	1.63	5.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	19.29	4.19	0.84	6.71	0.84	7.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	13.36	1.91	0.64	4.45	2.23	3.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	12.23	2.04	0.00	8.15	2.04	3.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	2.09	0.00	4.18	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	21.76	2.29	0.57	4.58	1.15	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	11.25	2.07	0.30	5.03	2.37	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	0.00	1.69	5.08	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	14.91	1.66	0.83	4.14	2.49	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.74	2.76	1.61	5.52	1.84	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	0.00	0.00	5.27	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.38	2.31	0.77	3.08	1.15	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	9.45	2.28	1.30	4.24	1.30	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.03	2.68	0.00	5.35	1.34	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	14.25	0.77	1.16	3.08	1.16	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	11.30	2.40	1.03	4.11	2.05	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	4.97	2.48	2.48	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	7.55	0.00	0.47	2.36	1.89	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	10.86	2.41	0.00	2.41	0.00	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	9.16	2.03	1.02	3.56	1.02	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	8.77	1.60	0.80	3.19	1.60	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	8.39	0.49	0.99	3.95	1.48	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	3.54	0.00	0.00	3.54	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	18.09	0.00	1.17	2.33	2.33	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	14.92	0.88	0.00	0.88	1.32	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	6.78	0.00	0.00	0.00	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	3.58	1.19	1.79	1.19	1.19	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	8.25	1.46	0.97	2.43	0.97	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	1.14	0.00	1.14	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	13.72	5.41	2.49	0.83	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	7.87	6.75	1.12	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	7.93	2.22	3.17	0.63	0.00	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.76	1.25	2.51	0.84	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	16.48	5.34	1.16	0.46	0.12	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.19	4.90	1.35	0.34	0.17	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	12.29	5.92	0.91	0.46	0.91	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.30	7.43	1.31	0.55	0.00	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	14.83	5.37	1.50	0.43	0.43	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	15.93	5.17	2.80	0.22	0.22	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	13.33	3.99	0.75	1.12	0.25	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.78	4.63	0.86	0.34	0.00	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	13.46	3.20	0.64	0.64	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	6.16	3.92	5.60	2.80	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.95	4.33	1.73	1.30	0.00	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	5.29	15.86	0.00	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	9.52	1.76	2.47	1.76	0.71	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.17	2.91	4.36	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.99	1.57	2.10	0.87	1.22	0.70
Hepatocyte, donor1	11523-119I2	14.53	1.21	3.63	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	10.77	3.23	5.39	0.00	2.15	0.00
Hepatocyte, donor3	11684-122I1	10.43	2.45	0.61	0.00	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	5.87	1.31	0.65	3.26	1.31	5.87
Intestinal epithelial cells (polarized), donor1	11246-116E4	11.36	4.72	1.40	1.57	0.70	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.49	2.06	0.69	0.41	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	3.18	0.00	9.55	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	8.31	5.54	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	10.01	2.50	2.50	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	7.69	5.13	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	4.57	4.57	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	9.75	8.12	3.25	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	25.01	1.67	6.67	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	3.63	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	26.47	7.94	2.65	1.32	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	3.33	1.11	0.00	2.22	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	0.00	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.90	5.67	4.41	4.41	1.26	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	20.11	9.28	1.55	1.55	4.64	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	28.43	6.46	1.29	1.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	24.15	6.44	0.00	1.61	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	23.90	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	31.78	4.07	4.89	1.63	1.63	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	21.83	5.88	3.78	1.68	1.68	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	27.33	7.23	4.82	3.21	4.02	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	4.62	3.69	0.00	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	30.16	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	19.83	5.66	1.89	1.42	1.42	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	13.60	4.53	2.72	0.91	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	29.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	27.98	5.38	5.38	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	7.62	2.54	0.00	5.08	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	30.61	5.10	5.10	0.64	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	23.69	5.47	7.29	0.00	7.29	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.00	12.85	4.28	1.43	0.71	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	49.77	3.32	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	17.59	5.25	2.16	1.54	0.62	2.16
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	14.05	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	9.43	3.14	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.03	9.04	4.17	2.78	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	42.05	6.64	8.85	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	6.48	3.24	3.24	0.00	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	38.36	8.72	1.74	2.62	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	20.25	11.25	6.75	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	10.45	0.00	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	44.80	9.60	3.20	2.13	5.33	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	6.93	6.93	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	2.85	0.00	2.85	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	11.97	1.84	0.00	3.68	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	18.15	6.05	0.00	6.05	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	18.63	0.00	0.00	6.21	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	33.84	6.34	4.23	3.17	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	8.98	3.59	2.20	1.14	0.65	0.57
Keratinocyte - epidermal, donor2	11349-117G8	13.47	4.69	2.34	1.17	1.17	0.59
Keratinocyte - epidermal, donor3	11421-118F8	7.10	3.69	3.31	0.76	0.38	0.85
Keratinocyte - oral, donor1	11251-116E9	7.15	1.70	1.59	0.34	1.02	0.57
Keratocytes, donor1	11527-119I6	9.97	4.13	3.44	0.69	2.06	1.72
Keratocytes, donor2	11607-120I5	8.20	0.00	3.52	1.17	2.34	0.00
Keratocytes, donor3	11688-122I5	10.67	5.14	2.77	1.19	0.59	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	6.59	0.00	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	11.87	3.24	2.16	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	7.15	2.42	1.73	0.92	1.27	0.92
Lens Epithelial Cells, donor3	11690-122I7	12.31	3.13	1.01	1.11	0.61	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.64	2.85	2.96	0.83	1.54	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.86	2.79	2.23	0.28	1.40	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	6.30	3.78	3.78	0.94	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.99	2.15	3.23	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	7.88	2.52	6.62	0.63	2.84	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.79	1.40	3.99	0.86	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4.92	1.23	4.10	0.41	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.02	3.03	3.54	0.76	2.02	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.93	2.39	3.24	1.13	1.55	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.56	3.56	2.77	1.19	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.82	0.97	2.91	0.78	1.16	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.89	1.67	4.44	1.11	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.97	2.79	3.14	1.39	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.72	0.48	3.34	0.72	1.19	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.59	1.79	3.16	0.82	1.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.24	1.54	1.85	0.31	1.23	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.99	3.12	3.43	0.31	1.87	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.32	2.20	3.29	0.55	0.73	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	2.96	2.63	0.66	0.99	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.93	1.76	4.69	0.00	0.88	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.98	1.99	3.49	0.75	1.74	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.79	2.42	5.33	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.04	2.69	2.69	0.81	0.81	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.60	1.82	2.12	1.51	0.91	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	2.59	1.04	3.11	1.04	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	3.35	1.26	2.09	1.05	1.47	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.01	1.95	3.91	0.90	0.75	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.82	3.44	5.50	0.00	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.27	1.88	2.07	0.38	0.94	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.88	1.48	3.18	0.74	1.27	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.72	1.94	3.88	0.48	3.88	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.28	1.65	2.98	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.82	2.23	3.10	0.12	1.73	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7.03	2.59	3.33	1.48	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.68	1.24	2.96	0.99	0.49	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.15	1.37	2.06	0.82	1.24	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.75	1.61	4.50	0.64	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	5.48	0.91	3.65	0.00	1.52	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	5.04	1.12	3.22	0.42	1.96	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.98	1.07	2.13	0.71	1.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.27	2.91	1.45	1.45	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.60	3.42	3.27	0.62	1.24	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.59	4.66	3.94	0.36	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	3.92	2.29	1.96	1.31	1.31	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.00	1.18	4.47	0.71	2.12	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.66	4.08	3.71	0.99	1.61	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.38	1.54	2.82	0.77	1.28	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.37	2.69	2.09	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	0.00	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	26.08	9.21	2.30	3.07	0.77	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	13.36	8.91	2.23	2.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	23.70	4.65	3.81	1.69	0.85	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.18	11.25	4.22	1.41	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	23.35	4.67	0.93	1.87	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.46	3.09	1.03	2.58	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	9.52	2.38	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.17	7.01	4.52	1.13	1.13	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.96	4.94	1.74	0.87	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	19.81	7.20	1.80	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	26.56	7.32	3.39	1.90	0.27	1.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.51	3.59	2.57	1.54	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	10.23	4.59	1.41	0.71	0.71	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.99	3.33	1.33	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	21.39	6.62	2.55	2.55	0.51	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	16.28	7.47	2.13	1.07	0.27	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.78	5.86	2.83	1.51	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	23.32	7.36	1.23	2.45	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	27.72	8.97	3.26	3.26	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	17.08	6.04	3.12	3.33	0.42	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	17.94	3.64	2.24	1.68	0.28	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	25.76	7.21	2.06	3.09	1.03	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.35	2.61	5.23	2.32	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	15.84	3.89	1.79	2.09	0.90	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	22.13	2.77	3.87	1.66	2.21	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	27.22	7.78	4.95	1.41	1.77	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.18	6.27	3.32	2.58	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	6.91	3.45	2.30	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.96	6.52	3.45	5.37	0.77	3.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	26.04	6.23	3.96	0.57	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	20.51	6.56	4.10	3.28	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	32.08	8.13	0.90	1.81	0.90	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	30.88	7.90	3.59	4.31	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.17	8.22	5.23	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	31.21	8.18	4.46	0.74	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	19.38	3.45	2.58	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	7.71	2.57	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	27.99	6.66	3.66	1.00	0.67	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	25.94	3.02	3.62	0.60	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	30.57	9.24	9.24	2.13	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	24.06	5.84	2.41	2.06	0.69	2.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.40	2.15	2.68	0.54	1.07	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	30.30	10.77	4.71	0.67	1.35	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	20.74	6.67	2.59	1.48	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	4.65	0.00	1.16	1.16	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	19.04	7.40	2.12	5.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	30.01	8.80	4.40	3.20	0.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	21.08	4.36	2.18	2.91	1.45	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	31.43	13.03	6.13	0.77	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	25.65	5.43	3.45	2.47	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	27.29	4.70	1.88	0.94	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	29.67	10.56	3.02	2.51	0.50	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	22.98	9.46	4.51	3.15	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	0.00	5.16	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	25.38	9.35	5.79	2.23	0.00	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	24.24	7.04	1.56	0.78	0.39	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.13	2.64	1.32	1.98	0.66	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.06	9.34	1.56	1.56	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	19.69	8.75	6.13	1.75	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	20.69	7.83	2.80	1.12	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	24.73	8.83	3.09	1.32	0.00	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.51	5.40	3.47	3.86	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	23.80	5.06	3.54	3.04	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	27.40	6.25	0.96	2.88	0.96	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.66	5.17	3.18	0.40	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.01	1.82	3.04	2.43	0.61	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.28	2.08	0.69	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	24.32	7.22	1.90	1.90	0.38	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.89	6.20	3.10	1.03	0.52	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	21.16	4.23	3.63	1.21	0.60	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.04	6.65	2.54	3.49	0.95	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	33.05	4.80	3.20	3.20	0.00	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	35.63	4.60	1.72	1.72	0.00	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	31.88	6.69	3.09	3.09	1.54	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	31.83	5.66	4.95	0.71	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	28.94	6.24	2.27	1.70	1.70	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	34.53	9.15	2.91	2.91	0.83	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	28.19	6.26	4.70	1.57	1.57	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	35.07	6.26	2.09	1.67	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.41	9.76	3.25	2.32	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	24.75	7.36	5.35	2.01	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	28.87	6.95	5.35	2.14	1.60	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	32.33	13.74	5.25	2.42	0.81	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	8.26	1.84	1.84	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	32.90	8.00	3.56	0.00	2.67	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	42.17	15.96	5.13	0.57	2.28	3.99
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	39.88	5.37	4.60	2.30	0.00	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	28.45	4.92	3.28	2.19	0.55	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	44.99	10.25	7.57	2.23	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	31.19	10.92	5.20	2.08	0.52	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	35.14	7.29	3.98	1.33	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	12.47	8.31	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	5.93	2.73	6.84	0.46	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	8.26	2.39	6.42	0.18	1.10	0.92
Macrophage - monocyte derived, donor3	11389-118C3	9.44	4.46	6.95	0.52	0.79	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.97	2.12	0.00	0.53	1.59	0.53
Mallassez-derived cells, donor2	11929-125I3	3.96	1.58	1.11	0.48	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	3.34	2.22	0.83	0.42	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	8.67	1.99	2.89	0.20	1.00	0.40
Mammary Epithelial Cell, donor2	11350-117G9	9.56	1.45	2.03	0.58	0.87	0.29
Mammary Epithelial Cell, donor3	11422-118F9	13.72	5.24	2.99	1.25	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	0.68	0.00	1.36	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	9.62	4.00	4.43	1.51	2.38	0.22
Mast cell, donor2	11565-120D8	11.59	3.86	6.54	1.19	2.67	0.00
Mast cell, donor3	11566-120D9	16.66	5.18	4.73	1.35	2.70	0.68
Mast cell, donor4	11567-120E1	14.54	3.72	6.56	1.60	1.77	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	17.52	1.89	3.44	0.44	0.55	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	14.59	1.17	11.09	2.33	2.33	0.00
Mast cell, expanded, donor5	11939-126A4	15.95	3.10	5.28	0.80	1.15	0.34
Mast cell, expanded, donor8	11941-126A6	17.91	4.35	5.19	1.00	2.18	1.34
Melanocyte - dark, donor1	11502-119F8	8.16	3.28	4.78	1.69	2.49	0.20
Melanocyte - dark, donor2	11582-120F7	5.54	0.69	1.73	0.00	1.38	0.00
Melanocyte - dark, donor3	11663-122F7	10.14	3.84	5.14	0.80	1.38	0.22
Melanocyte - light, donor1	11274-116H5	18.57	5.41	6.11	1.65	1.41	0.94
Melanocyte - light, donor2	11351-117H1	21.84	2.73	3.41	2.05	0.68	1.36
Melanocyte - light, donor3	11423-118G1	10.41	1.73	5.20	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	17.39	7.08	5.73	1.04	0.83	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	12.37	3.23	3.23	0.54	0.81	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	9.37	3.48	1.61	1.87	1.61	0.54
Meningeal Cells, donor1	11493-119E8	11.04	1.36	3.47	1.12	0.99	0.50
Meningeal Cells, donor2	11573-120E7	8.36	2.20	2.20	1.76	0.88	1.32
Meningeal Cells, donor3	11654-122E7	9.37	2.28	3.59	0.73	0.49	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	6.56	0.57	2.28	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.37	1.51	1.41	0.60	0.20	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	31.54	7.88	9.20	5.26	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	14.35	2.15	5.74	0.00	0.72	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.89	0.85	1.69	0.42	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	6.03	2.01	2.51	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.91	3.96	3.52	0.22	1.10	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.88	2.92	2.92	1.46	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.64	3.68	2.86	1.02	1.23	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	6.23	1.25	2.35	0.14	0.69	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.78	0.74	5.20	1.49	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	6.32	1.58	1.71	0.92	0.79	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.31	1.19	1.48	0.30	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.33	1.28	2.56	0.00	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	10.63	5.67	4.25	0.35	0.35	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	4.07	1.25	2.50	0.31	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	6.53	0.73	5.08	1.45	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	9.28	2.12	1.06	0.27	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	9.01	2.50	1.50	1.50	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	9.18	2.10	1.66	0.65	0.22	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	10.80	2.70	8.10	2.70	5.40	5.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	9.85	3.94	6.40	0.49	1.72	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	6.77	3.24	6.77	1.77	1.77	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	10.37	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.06	2.17	4.03	0.31	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	5.39	1.04	5.39	0.21	1.04	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	0.00	0.00	4.63	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	8.76	4.75	4.75	1.50	2.25	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	9.31	4.19	4.65	0.47	1.86	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.10	2.85	6.30	0.61	1.42	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	8.71	2.38	5.94	0.00	3.96	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.08	0.88	5.31	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	3.80	1.14	7.22	0.38	2.66	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	2.63	2.63	0.00	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3.61	1.27	3.40	0.00	1.27	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	8.29	0.92	8.29	0.00	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	5.37	1.49	2.98	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	0.00	3.35	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	2.26	1.51	1.76	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.75	1.43	4.75	0.00	1.43	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.55	0.55	1.11	0.00	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	2.99	0.69	2.53	0.00	0.92	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2.94	1.05	3.37	0.63	1.05	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.08	1.02	1.83	0.00	1.22	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.43	1.50	2.57	0.00	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.89	0.89	3.33	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.41	0.88	1.31	0.22	0.88	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.59	0.51	2.53	1.52	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.72	0.54	1.36	0.27	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	3.53	0.59	2.35	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	0.00	1.09	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	0.96	1.92	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	2.80	0.00	2.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	1.37	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	1.00	2.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	2.04	4.08	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.88	0.88	0.88	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	1.10	1.10	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	4.48	3.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.45	1.49	2.48	0.50	1.98	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	0.00	2.09	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	2.21	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.47	2.05	1.71	0.34	1.03	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.94	1.31	5.69	0.00	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.68	3.91	2.13	0.71	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	7.29	1.96	3.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.82	1.66	1.66	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	1.75	2.33	0.00	2.33	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.64	2.71	2.71	0.00	0.90	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.84	0.83	4.17	0.42	1.25	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	0.92	1.85	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.14	1.71	3.41	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.28	1.38	2.63	0.28	0.41	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	3.11	1.81	1.55	0.00	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.01	3.86	4.29	0.00	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	2.54	2.54	0.64	1.91	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.87	0.27	1.33	0.00	0.53	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	4.49	2.10	2.69	0.00	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	3.53	2.97	3.11	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.96	2.23	1.59	0.00	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4.86	3.10	3.76	0.66	1.33	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.17	2.65	3.03	1.14	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.98	2.27	1.99	0.28	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.39	2.95	4.92	0.49	1.23	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.87	4.56	5.87	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.94	1.18	3.82	0.59	0.29	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	5.19	2.31	5.77	0.58	0.86	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	3.71	1.65	3.71	0.41	2.47	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	3.28	1.49	2.68	0.30	1.49	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	1.78	1.78	0.00	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	9.53	4.27	6.57	0.33	1.64	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	2.10	5.26	0.00	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	5.73	2.77	5.93	0.59	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	11.18	0.00	8.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	4.13	4.13	6.38	1.13	0.75	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	6.66	2.40	6.66	1.07	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	3.85	1.47	4.75	0.00	0.34	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	3.68	3.68	3.68	0.74	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.76	5.86	7.33	0.37	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	1.56	6.22	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.07	0.53	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	7.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	4.04	6.06	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.11	1.69	2.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.65	2.80	3.02	0.43	1.08	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	5.75	0.00	1.05	1.05	2.09	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.01	4.00	4.00	2.00	0.00	2.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	18.36	9.18	2.50	0.83	0.00	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	16.16	2.66	2.28	0.19	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	14.36	4.79	4.79	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.88	6.80	6.12	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	1.84	0.00	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.21	5.44	2.93	0.84	0.84	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.71	6.51	1.86	0.93	0.23	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.51	7.03	4.05	1.08	0.54	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.30	2.94	2.10	0.21	0.63	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.43	4.96	2.98	0.50	0.50	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.93	1.62	2.44	0.27	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.07	3.63	1.36	0.23	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	13.06	4.74	1.63	0.49	0.49	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.94	2.37	2.37	0.36	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.67	4.77	2.12	1.06	1.06	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.80	3.00	3.60	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.92	0.98	0.66	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.92	5.69	2.11	0.49	0.65	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.99	2.47	1.94	0.53	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.03	4.92	3.52	2.11	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.57	2.30	3.22	0.00	0.92	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	13.50	4.18	2.89	0.96	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	5.52	0.69	1.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	11.36	3.12	1.56	0.45	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.55	2.96	1.27	1.27	0.42	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.34	2.37	1.42	0.71	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.31	3.43	1.72	0.86	1.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.99	4.33	1.33	0.33	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.21	0.45	0.00	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.90	1.59	1.19	0.00	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	3.71	2.79	0.93	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.49	1.89	1.89	0.38	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.78	4.89	1.96	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.82	4.79	2.18	0.44	0.87	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.40	3.17	0.90	0.90	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	3.53	1.76	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.96	3.99	1.99	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	10.42	4.96	1.49	0.00	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	10.34	8.42	1.15	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.31	3.93	0.91	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.95	2.65	1.11	0.88	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.74	4.07	2.03	0.68	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.93	1.83	1.22	1.22	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.59	6.61	0.63	0.00	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.13	4.54	2.42	0.00	0.30	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	8.70	1.58	2.37	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	2.27	1.13	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	9.07	2.24	1.74	0.25	0.37	0.12
Myoblast, donor2	11322-117D8	16.30	3.84	3.84	0.58	0.38	0.19
Myoblast, donor3	11398-118D3	11.77	2.86	4.04	0.50	1.01	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	9.19	4.82	2.04	1.75	0.58	1.61
Natural Killer Cells, donor1	11230-116C6	5.54	1.85	0.92	1.23	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	4.22	1.51	1.21	0.30	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	6.44	2.02	1.10	0.55	0.18	0.18
Neural stem cells, donor1	11275-116H6	18.87	2.18	5.08	1.45	0.36	1.09
Neural stem cells, donor2	11352-117H2	13.48	0.00	1.93	0.00	1.93	0.00
Neurons, donor1	11494-119E9	11.38	5.69	4.55	0.00	0.00	1.14
Neurons, donor2	11574-120E8	18.27	2.20	2.20	0.44	2.20	0.66
Neurons, donor3	11655-122E8	11.51	2.47	4.93	1.64	1.64	0.82
Neutrophils, donor1	11233-116C9	0.93	2.78	1.86	0.93	0.00	0.93
Neutrophils, donor2	11314-117C9	0.00	5.80	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	5.50	3.67	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	6.77	1.90	2.61	0.95	0.59	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	6.19	1.30	1.63	1.63	2.93	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	8.22	2.81	2.61	0.80	1.40	0.80
Olfactory epithelial cells, donor1	11933-125I7	5.09	2.89	3.44	0.69	1.24	0.83
Olfactory epithelial cells, donor2	11934-125I8	8.40	3.62	3.18	0.43	0.58	1.16
Olfactory epithelial cells, donor3	11935-125I9	9.19	3.18	2.95	1.25	0.68	0.34
Olfactory epithelial cells, donor4	11936-126A1	11.69	4.19	4.68	0.88	0.68	0.88
Oligodendrocyte - precursors, donor1	11496-119F2	11.43	4.81	2.41	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	16.80	3.40	2.34	0.85	0.85	0.43
Osteoblast - differentiated, donor2	11353-117H3	22.86	5.72	0.00	0.00	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	19.24	8.69	2.48	0.62	0.00	1.24
Osteoblast, donor1	11277-116H8	17.78	4.10	4.10	1.76	1.56	0.59
Osteoblast, donor2	11354-117H4	15.45	2.11	4.21	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	17.24	6.75	4.27	0.53	0.36	0.36
Pancreatic stromal cells, donor1	11249-116E7	9.10	2.78	2.70	0.51	0.42	0.08
Pericytes, donor1	11491-119E6	12.35	1.78	3.78	1.45	3.34	0.56
Pericytes, donor2	11571-120E5	15.17	1.81	1.36	2.04	2.04	0.45
Pericytes, donor3	11652-122E5	12.41	3.66	2.64	0.81	0.81	0.81
Perineurial Cells, donor1	11499-119F5	5.20	4.07	2.49	0.23	0.45	0.34
Perineurial Cells, donor2	11579-120F4	6.07	1.93	2.76	0.64	1.01	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	5.42	0.64	1.91	0.96	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	4.65	1.22	1.22	0.24	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	5.69	3.11	1.16	0.65	0.39	0.13
Placental Epithelial Cells, donor1	11278-116H9	21.76	6.46	2.15	0.96	0.48	1.20
Placental Epithelial Cells, donor2	11355-117H5	28.83	2.22	5.54	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	19.63	4.52	3.14	1.57	0.98	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	22.15	3.16	5.06	0.95	0.63	0.95
Preadipocyte - breast, donor1	11467-119B9	17.45	2.81	4.69	0.75	0.38	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	5.61	2.35	2.48	0.13	0.39	0.13
Preadipocyte - breast, donor2	11328-117E5	15.08	2.70	5.18	0.23	1.35	0.00
Preadipocyte - omental, donor1	11468-119C1	20.67	3.62	5.22	1.07	2.13	0.43
Preadipocyte - omental, donor2	11329-117E6	13.53	1.31	3.49	0.44	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	19.77	6.02	4.01	1.29	1.43	0.43
Preadipocyte - perirenal, donor1	11469-119C2	26.58	0.00	2.95	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	14.43	3.69	2.15	0.92	0.61	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	14.17	2.83	4.25	0.53	1.06	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	15.67	3.41	2.89	1.19	0.34	0.51
Preadipocyte - visceral, donor1	11280-116I2	12.76	2.79	4.66	0.56	0.93	0.19
Preadipocyte - visceral, donor2	11357-117H7	15.19	5.52	7.82	0.92	1.38	0.92
Preadipocyte - visceral, donor3	11429-118G7	10.97	2.40	5.96	0.10	0.84	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	15.84	5.88	1.81	2.72	1.66	3.47
Prostate Epithelial Cells, donor2	11331-117E8	8.80	2.57	1.49	1.08	0.27	0.54
Prostate Epithelial Cells, donor3	11404-118D9	20.21	7.35	0.98	0.24	0.24	0.49
Prostate Stromal Cells, donor1	11254-116F3	8.54	3.76	2.96	0.46	0.80	0.34
Prostate Stromal Cells, donor2	11332-117E9	13.45	6.28	5.38	1.08	0.72	0.18
Prostate Stromal Cells, donor3	11405-118E1	8.03	4.07	2.61	1.36	0.52	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.39	1.09	2.92	1.09	2.55	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	8.94	1.66	1.39	0.35	0.97	0.21
Renal Epithelial Cells, donor1	11517-119H5	25.87	6.09	4.06	3.55	4.57	0.00
Renal Epithelial Cells, donor2	11597-120H4	13.52	3.56	1.42	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	13.02	3.81	1.59	1.06	1.69	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	9.53	4.77	6.13	1.36	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.45	4.72	4.58	1.21	0.81	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	12.88	4.44	4.88	2.44	2.22	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	19.96	5.32	4.66	3.33	3.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	13.21	3.30	2.64	1.54	2.42	0.66
Renal Mesangial Cells, donor2	11598-120H5	10.03	1.88	1.88	1.25	1.88	0.00
Renal Mesangial Cells, donor3	11679-122H5	13.87	3.88	3.61	1.66	1.66	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.08	5.91	2.68	1.07	1.34	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.39	5.48	1.27	0.84	0.84	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	16.39	4.05	3.09	1.35	1.54	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	8.56	1.04	1.56	0.52	0.78	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	13.08	1.42	1.14	0.57	1.14	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	11.32	2.06	1.03	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.77	2.26	2.51	1.25	0.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	10.42	3.21	2.81	0.94	1.07	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	7.15	1.79	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.60	2.20	0.00	0.55	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	8.12	1.74	1.16	0.00	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	8.71	0.78	0.78	0.26	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	10.13	3.08	1.09	0.50	0.50	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	7.92	2.79	1.23	0.33	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	5.46	1.24	0.99	0.50	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	11.54	2.91	1.40	0.70	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	9.25	2.08	1.62	0.23	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	8.90	2.46	1.10	0.00	0.68	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	11.80	2.42	0.45	0.00	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	7.88	2.69	1.25	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.89	4.45	1.15	0.57	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	9.87	2.79	1.40	0.43	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	10.18	3.76	1.99	0.66	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	12.04	2.10	1.53	0.19	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	8.76	2.14	0.93	0.28	0.37	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	6.58	1.69	1.88	0.38	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.41	4.25	1.06	0.13	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	9.25	3.41	1.56	0.19	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	8.02	3.25	1.15	0.38	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.36	2.46	0.96	0.11	0.53	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	11.21	1.68	0.84	1.12	0.28	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	7.35	3.25	1.71	0.85	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.03	1.46	1.28	0.18	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	9.32	4.54	0.98	0.49	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	11.42	3.36	0.94	0.40	0.27	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	11.79	1.65	1.18	0.47	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	9.52	3.17	0.60	0.20	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	10.06	3.27	0.70	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	12.65	2.28	1.24	0.41	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	9.95	3.54	0.88	0.22	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	8.98	3.34	0.84	0.00	0.42	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	14.80	4.04	1.08	0.13	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	10.22	3.07	1.53	0.68	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	8.10	3.28	1.54	0.19	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.04	1.20	0.86	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	10.70	4.39	1.92	0.27	0.27	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	9.36	2.30	0.33	0.33	0.16	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.03	3.07	0.85	0.51	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	7.99	4.29	0.89	0.00	0.44	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	7.20	3.73	0.27	0.27	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	11.20	3.73	1.24	0.14	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	10.24	3.10	0.71	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	9.47	3.43	1.21	0.60	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	12.15	3.30	0.94	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	10.13	4.19	2.45	0.00	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	8.76	5.44	1.51	0.60	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	15.42	2.94	1.96	0.24	0.49	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	8.01	2.47	1.16	0.58	0.00	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	13.99	4.26	2.43	0.00	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	11.45	3.62	0.90	0.90	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	18.32	4.07	1.81	0.90	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	15.88	7.49	1.50	0.00	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.88	2.13	1.30	0.59	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	14.51	5.98	2.35	1.07	0.64	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	12.62	4.21	3.61	1.20	0.60	0.60
Schwann Cells, donor1	11498-119F4	16.93	4.51	4.70	0.56	1.13	0.56
Schwann Cells, donor2	11578-120F3	6.80	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	9.42	1.75	5.04	1.10	0.88	0.44
Sebocyte, donor1	11220-116B5	14.24	6.03	4.38	0.55	1.10	0.00
Sebocyte, donor2	11301-117B5	10.57	3.22	2.30	0.00	0.00	0.92
Sebocyte, donor3	11378-118B1	14.63	5.77	2.27	0.62	1.44	0.21
Sertoli Cells, donor1	11255-116F4	9.94	3.31	3.31	0.00	4.97	1.66
Sertoli Cells, donor2	11333-117F1	14.12	0.00	2.82	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	20.15	3.87	7.57	1.50	3.17	1.14
Skeletal Muscle Cells, donor2	11358-117H8	18.07	4.34	5.06	2.89	3.61	0.72
Skeletal Muscle Cells, donor3	11430-118G8	16.72	8.36	4.18	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	8.01	2.20	1.73	0.63	0.79	0.79
Skeletal Muscle Cells, donor5	11455-119A6	9.66	2.38	2.38	0.45	1.04	0.30
Skeletal Muscle Cells, donor6	11459-119B1	8.31	3.08	2.77	0.31	1.08	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	5.42	1.13	2.65	0.25	1.13	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	6.42	1.71	4.14	1.28	1.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	8.53	3.47	2.68	1.09	1.49	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.14	3.37	3.12	1.01	1.10	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.03	4.34	5.79	3.62	3.62	3.62
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.27	3.03	2.34	0.96	1.65	0.96
Skin - palm, donor1	10286-104F7	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.38	3.46	0.58	0.00	0.14	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	13.90	2.45	3.27	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.70	2.73	3.38	0.91	0.52	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	9.04	2.09	1.53	1.11	0.14	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	12.94	6.75	1.83	1.27	0.42	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	8.46	2.96	1.48	0.85	0.21	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	17.54	6.45	2.92	1.05	0.90	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.73	3.09	2.16	0.93	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.23	1.56	1.11	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.23	1.76	2.35	1.18	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	13.26	3.76	5.30	0.66	0.88	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.99	4.33	3.94	1.58	1.58	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.91	3.09	3.09	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	3.00	1.00	3.00	1.00	1.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.31	5.06	3.06	1.60	0.93	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	10.64	2.88	3.32	0.44	0.66	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	11.14	3.46	1.79	0.90	0.77	1.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	7.49	2.28	2.60	0.65	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	5.02	2.07	1.77	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.11	2.70	1.14	0.71	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	12.69	3.25	2.44	0.65	0.98	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	12.18	2.74	2.74	0.61	1.83	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	14.14	3.03	3.54	0.76	2.53	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	13.35	4.77	3.81	0.95	1.43	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	5.01	1.77	1.03	0.15	1.18	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.82	3.01	1.94	0.43	1.29	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	7.45	3.25	2.41	1.15	0.84	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.16	3.87	4.64	1.08	2.32	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	4.31	4.31	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	9.56	2.99	2.39	0.60	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	12.97	4.10	1.71	0.34	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	3.61	0.71	1.26	0.31	0.31	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	13.89	4.33	4.13	1.41	0.91	1.61
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.11	4.55	2.50	0.68	0.91	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.87	4.83	3.02	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	7.42	2.91	3.44	1.06	1.32	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	8.79	1.60	2.26	1.33	0.80	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	8.51	3.13	2.88	0.63	1.50	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	7.36	2.28	3.30	0.00	0.51	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	13.87	5.88	6.78	1.36	1.06	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	4.50	4.50	1.50	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	7.75	1.29	20.68	2.58	2.58	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.02	2.79	10.23	2.79	3.26	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	13.13	5.05	4.54	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	7.83	3.76	2.82	0.63	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.96	2.36	0.88	0.00	0.29	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	6.33	2.42	2.75	0.33	0.67	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.54	2.34	2.80	0.00	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.94	4.03	3.31	1.30	0.72	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.49	4.84	4.84	2.04	1.53	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	11.47	6.02	3.57	0.75	1.32	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	8.24	3.35	1.12	0.00	0.56	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.22	3.52	2.01	0.59	1.01	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	15.71	1.43	1.90	0.48	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.77	2.45	2.69	0.73	1.96	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	12.81	3.54	1.99	1.10	1.33	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	5.56	4.10	4.39	0.00	1.17	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	9.52	1.94	1.55	0.19	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.67	3.70	3.44	0.53	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1.86	0.74	0.37	0.00	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.47	1.80	2.52	0.00	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.94	1.99	1.42	0.28	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.39	1.97	7.48	0.79	0.79	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	6.60	1.02	1.52	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	7.99	1.20	2.80	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	10.45	0.84	2.09	0.42	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	8.71	3.21	1.83	1.83	0.92	0.46
Synoviocyte, donor1	11291-117A4	12.62	2.19	3.70	0.34	0.84	0.34
Synoviocyte, donor2	11368-117I9	12.91	2.85	3.86	1.17	0.17	0.50
Synoviocyte, donor3	11440-118H9	9.61	3.13	2.46	0.22	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	16.08	5.00	6.43	1.79	1.07	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	3.96	5.95	3.96	1.98	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	7.64	2.78	3.01	1.16	1.85	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	10.32	2.65	1.36	0.72	0.65	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	13.92	5.41	3.48	1.16	1.55	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	12.03	4.58	4.01	0.00	1.15	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	12.18	1.23	3.20	0.98	0.62	0.62
Urethra, donor2	10319-105A4	8.99	3.60	7.19	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	11.16	2.39	1.86	1.86	0.80	0.27
Urothelial Cells, donor2	11600-120H7	8.01	2.80	2.00	0.80	0.40	0.40
Urothelial Cells, donor3	11681-122H7	12.84	4.81	2.06	0.46	0.69	0.00
Urothelial cells, donor0	11216-116B1	12.71	2.90	1.78	0.00	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	14.24	4.45	1.78	0.89	0.89	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	12.87	7.15	5.72	0.00	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	10.95	4.11	5.48	2.05	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	15.15	4.48	4.13	1.03	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	11.04	1.74	2.91	1.74	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	13.54	5.21	0.00	0.00	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	8.26	1.84	5.51	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	14.61	4.56	5.48	1.83	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	8.14	4.19	1.48	4.56	2.96	3.58
Wilms' tumor cell line:HFWT	10597-108E3	20.24	2.64	1.76	1.76	0.00	4.40
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	13.69	3.63	2.23	0.28	0.28	1.40
achilles tendon, donor2	10292-104G4	4.13	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	5.10	2.04	3.31	2.04	0.51	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	4.18	1.39	0.93	3.71	1.63	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	8.55	1.78	0.71	1.90	0.59	1.54
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	8.71	3.54	2.99	5.17	1.63	1.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	7.31	5.06	4.50	4.50	2.81	3.94
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	9.73	5.50	5.50	1.48	1.90	2.33
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	8.17	1.63	3.54	1.91	1.09	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	6.17	3.53	1.76	1.76	0.00	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	6.94	2.04	3.27	3.68	2.45	3.27
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	8.54	1.55	4.27	6.21	1.94	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	6.07	3.31	4.23	2.94	2.02	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	3.90	3.90	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	5.81	2.09	3.02	4.65	2.79	3.49
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	12.17	3.62	7.25	1.29	2.33	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	9.06	2.92	5.55	1.46	0.88	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	15.34	8.37	6.51	7.90	3.72	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	6.99	2.06	3.29	0.00	0.41	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	26.70	15.65	7.98	2.76	0.31	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	23.47	8.96	8.53	2.56	3.41	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	24.87	9.10	7.89	0.61	1.82	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	21.42	8.18	9.39	2.17	1.44	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	8.02	4.45	5.35	1.78	1.34	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	13.01	2.67	2.00	1.33	1.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	5.57	1.86	1.86	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	11.68	4.90	2.64	1.13	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	11.34	1.31	4.36	1.31	1.31	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	11.25	1.87	3.75	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	8.95	5.89	3.06	2.35	1.65	0.71
adipose tissue, adult, pool1	10010-101C1	10.39	1.86	5.89	0.47	0.62	0.16
adipose, donor1	10184-103D4	18.77	1.76	1.17	1.76	0.59	1.17
adipose, donor2	10185-103D5	22.71	2.03	1.22	8.11	2.84	7.70
adipose, donor3	10186-103D6	15.25	3.54	2.18	7.90	2.18	5.99
adipose, donor4	10187-103D7	15.60	1.73	0.00	6.93	0.87	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.99	3.00	0.32	0.95	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	5.34	2.00	1.87	0.13	0.53	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	16.44	8.58	6.79	3.22	0.36	1.43
amniotic membrane cells, donor1	12235-129G3	13.91	1.62	3.01	0.23	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	15.89	5.41	4.06	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	10.31	1.47	1.77	0.00	0.00	0.29
amygdala - adult, donor10196	10167-103B5	16.60	1.19	3.56	0.00	2.37	0.00
amygdala, adult, donor10252	10151-102I7	21.09	4.66	5.47	1.42	1.42	1.22
amygdala, newborn, donor10223	10360-105E9	19.04	0.97	1.61	0.65	0.65	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	5.48	2.42	5.86	1.27	1.78	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	24.49	8.82	5.29	1.76	0.66	2.65
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	13.36	2.00	2.00	4.01	2.00	3.67
aorta, adult, pool1	10052-101G7	4.90	0.98	3.53	0.00	0.20	0.20
appendix, adult	10189-103D9	10.09	4.27	3.10	2.33	3.49	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	10.66	3.78	1.38	2.75	1.38	3.10
artery, adult	10190-103E1	8.15	4.08	4.08	1.36	4.08	1.36
astrocytoma cell line:TM-31	10425-106D2	10.87	1.45	4.20	1.45	3.62	1.16
b cell line:RPMI1788	10427-106D4	2.23	0.89	1.64	0.74	1.93	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.66	3.88	3.33	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	8.93	5.26	0.99	0.40	0.10	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	10.54	5.02	2.18	1.67	0.17	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	9.51	5.59	5.03	3.36	1.68	0.56
bladder, adult, pool1	10011-101C2	11.73	1.20	5.21	0.54	1.85	0.00
blood, adult, pool1	10053-101G8	4.43	0.00	6.64	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	3.43	2.57	3.43	0.00	1.71	0.00
bone marrow, adult	10192-103E3	4.72	1.35	4.72	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	12.30	1.03	8.20	4.10	2.05	0.00
brain, adult, pool1	10012-101C3	14.48	2.78	8.69	1.22	3.12	0.78
brain, fetal, pool1	10085-102B4	34.73	5.34	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	14.87	6.28	1.98	1.98	1.32	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	11.86	4.37	2.50	1.62	0.50	1.00
breast, adult, donor1	10080-102A8	17.68	5.68	5.68	1.26	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	13.97	7.88	1.40	1.65	0.00	1.91
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	13.30	6.80	1.24	3.40	0.31	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	2.99	0.46	0.69	0.00	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.25	6.05	2.91	1.69	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	16.93	2.82	0.00	0.94	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	14.44	6.78	2.95	0.66	0.33	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	15.21	6.34	1.27	0.32	0.32	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	6.39	1.33	0.80	0.27	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	29.93	0.00	2.30	1.15	3.45	0.00
caudate nucleus, adult, donor10252	10164-103B2	21.92	4.18	5.86	2.18	3.68	0.67
caudate nucleus, adult, donor10258	10379-105H1	35.91	1.53	6.88	1.53	1.53	1.53
caudate nucleus, newborn, donor10223	10354-105E3	17.95	1.10	1.10	1.83	1.10	0.37
cerebellum - adult, donor10196	10173-103C2	5.83	0.00	5.83	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	13.24	2.99	5.98	0.64	0.85	0.21
cerebellum, adult, pool1	10083-102B2	11.38	4.14	3.79	1.38	2.07	0.34
cerebellum, newborn, donor10223	10357-105E6	16.61	1.66	2.49	0.83	1.66	0.00
cerebral meninges, adult	10188-103D8	11.09	2.27	5.29	0.76	1.51	0.50
cerebrospinal fluid, donor2	10294-104G6	4.39	2.92	2.19	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	16.10	5.03	1.29	1.58	0.29	0.86
cervical cancer cell line:ME-180	10553-107I4	24.53	12.10	3.98	2.15	1.33	1.66
cervix, adult, pool1	10013-101C4	11.55	3.15	5.77	1.68	2.73	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	9.20	3.48	4.74	0.84	1.81	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	1.31	2.61	2.61	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	24.61	6.09	1.74	3.23	1.24	1.86
choriocarcinoma cell line:SCH	10785-110H2	11.58	4.56	0.49	2.09	0.74	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	15.42	9.01	2.37	1.66	3.08	0.47
chorionic membrane cells, donor1	12238-129G6	13.11	3.70	1.99	0.28	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	13.22	4.28	2.29	0.80	0.89	0.50
chorionic membrane cells, donor3	12240-129G8	13.74	2.20	4.40	0.55	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	9.09	3.03	2.02	2.02	1.01	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	17.87	8.64	6.15	3.84	1.15	2.11
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	12.88	8.24	3.38	3.80	3.17	2.53
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	9.76	1.03	1.03	0.51	1.28	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	13.55	2.42	0.73	1.21	0.00	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	11.61	2.44	2.65	1.22	0.41	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	12.96	3.83	2.65	0.88	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	8.86	2.87	3.91	2.09	0.78	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	2.74	0.91	0.46	0.91	0.23	0.69
clear cell carcinoma cell line:TEN	10636-108I6	11.10	3.82	0.87	0.52	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	8.97	2.75	0.73	2.38	0.37	0.92
colon carcinoma cell line:COLO-320	10420-106C6	9.12	2.28	4.18	3.04	1.90	2.28
colon, adult, donor1	10082-102B1	17.85	8.33	4.76	0.00	2.38	0.00
colon, adult, pool1	10014-101C5	12.93	5.17	8.11	1.76	2.23	0.24
colon, fetal, donor1	10070-101I7	6.18	2.47	1.24	0.62	1.85	0.62
common myeloid progenitor CMP, donor1	12130-128D6	13.75	0.00	0.00	9.17	4.58	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.05	1.70	1.70	0.85	1.27	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	11.62	2.11	3.17	1.96	1.21	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	9.73	1.13	1.69	1.41	0.99	0.85
corpus callosum, adult, pool1	10042-101F6	8.51	2.43	6.85	0.66	3.32	0.11
cruciate ligament, donor2	10295-104G7	0.81	0.81	1.62	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	7.22	7.22	1.61	3.21	2.41	0.00
diencephalon, adult	10193-103E4	9.60	0.96	3.84	0.72	1.44	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.81	2.98	1.38	3.90	1.15	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	15.39	5.64	3.08	4.36	1.28	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.39	6.26	2.41	0.72	1.20	0.72
ductus deferens, adult	10196-103E7	5.98	1.99	3.49	1.50	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	10.08	5.76	2.88	4.32	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	13.24	0.74	4.41	0.00	0.74	1.47
dura mater, adult, donor1	10041-101F5	3.55	1.40	3.06	0.58	0.50	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.54	1.33	3.11	5.11	4.66	4.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.62	3.30	1.29	1.72	1.29	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	17.88	4.93	3.70	5.55	1.85	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	12.41	4.24	3.94	1.51	1.82	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.36	5.25	7.41	4.01	1.54	2.78
embryonic pancreas cell line:2C6	10603-108E9	18.39	3.94	3.94	7.88	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	17.09	4.36	0.67	1.68	1.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	11.42	3.08	4.17	0.72	0.54	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.27	2.73	1.29	0.32	0.16	0.32
epidermoid carcinoma cell line:A431	10426-106D3	10.34	3.56	3.45	1.89	1.00	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	15.18	8.36	0.99	1.65	0.11	1.54
epididymis, adult	10197-103E8	9.21	2.09	4.60	0.42	1.05	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	8.87	1.95	4.26	0.71	1.95	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1.97	1.57	1.57	3.15	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	25.82	10.09	2.36	1.83	0.13	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	28.44	13.39	3.25	2.17	0.79	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	26.78	13.00	1.90	1.34	0.11	1.79
esophagus, adult, pool1	10015-101C6	13.59	3.93	5.52	0.64	1.38	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	16.03	3.13	3.13	1.75	1.25	0.63
eye - muscle inferior rectus, donor1	10272-104E2	14.49	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	0.00	4.21	2.10	2.10	2.10
eye - muscle medial, donor2	10299-104H2	4.46	1.49	0.00	4.46	1.49	0.00
eye - muscle superior, donor2	10297-104G9	3.44	1.15	3.44	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	0.00	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	4.07	1.53	1.53	1.27	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	6.03	3.21	6.15	2.44	1.67	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	5.94	2.61	0.00	1.42	0.71	0.47
frontal lobe, adult, pool1	10040-101F4	20.45	3.28	10.41	1.13	2.16	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	21.32	9.91	1.80	0.30	0.60	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	4.11	1.28	2.47	0.37	0.64	0.64
gall bladder, adult	10198-103E9	10.38	3.86	6.28	0.97	1.21	0.48
gamma delta positive T cells, donor1	11937-126A2	19.33	5.37	4.83	0.54	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	14.57	5.23	3.73	2.24	0.75	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.07	7.82	2.53	1.06	1.69	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	20.31	10.64	5.61	3.29	2.13	1.74
gastric cancer cell line:AZ521	10549-107H9	17.22	4.59	2.79	1.15	0.33	0.66
gastric cancer cell line:GSS	10560-108A2	6.41	0.00	2.75	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	5.48	1.14	1.37	2.06	2.74	1.14
giant cell carcinoma cell line:LU65	10487-107B1	9.18	2.29	1.03	0.46	0.34	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	9.38	3.64	3.36	2.66	1.96	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	32.92	15.46	3.74	3.24	1.00	2.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.98	2.01	2.64	0.42	0.42	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	8.85	2.25	1.83	0.28	1.12	0.56
glioblastoma cell line:T98G	10485-107A8	6.18	1.21	3.64	0.33	1.55	0.44
glioma cell line:GI-1	10413-106B8	14.64	7.91	2.34	0.59	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	16.04	1.46	3.64	0.73	2.19	1.46
globus pallidus, adult, donor10252	10161-103A8	10.74	2.20	4.64	0.98	2.93	0.49
globus pallidus, adult, donor10258	10367-105F7	8.22	0.00	5.48	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	14.92	1.60	2.66	3.20	1.60	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	14.68	0.00	4.89	2.45	4.89	12.24
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	10.24	2.56	1.92	0.64	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	16.99	0.92	0.46	4.13	1.84	1.38
hIPS +CCl2, biol_rep2	14384-156C1	19.66	0.91	0.00	4.57	1.37	2.74
hIPS +CCl2, biol_rep3	14385-156C2	21.26	1.29	1.29	5.80	0.00	4.51
hIPS, biol_rep1	14380-156B6	15.81	0.00	0.00	7.19	1.44	2.87
hIPS, biol_rep2	14381-156B7	8.92	0.69	2.74	2.06	2.06	4.12
hIPS, biol_rep3	14382-156B8	15.45	0.00	3.31	1.10	1.10	2.21
hairy cell leukemia cell line:Mo	10712-109I1	5.17	1.44	1.15	0.86	0.57	0.29
heart - mitral valve, adult	10205-103F7	7.18	0.90	3.89	0.00	2.09	0.30
heart - pulmonic valve, adult	10206-103F8	5.75	0.52	3.40	0.26	1.31	0.26
heart - tricuspid valve, adult	10207-103F9	19.15	0.83	5.00	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	9.18	3.47	5.10	1.02	0.61	0.20
heart, adult, diseased, donor1	10051-101G6	4.68	2.98	8.52	0.43	2.13	0.00
heart, adult, pool1	10016-101C7	6.90	2.07	3.91	0.46	1.84	0.69
heart, fetal, pool1	10046-101G1	6.67	1.44	2.36	1.23	1.64	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	9.56	4.63	1.54	0.62	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	10.70	5.95	0.00	4.76	1.19	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	6.85	4.75	0.88	3.09	1.99	1.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	5.95	3.88	1.58	1.70	1.09	1.82
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	7.58	4.65	2.22	2.93	1.11	2.53
hepatoma cell line:Li-7	10484-107A7	5.34	4.00	2.11	1.78	2.56	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.05	5.13	0.80	2.01	0.70	1.41
hippocampus - adult, donor10196	10169-103B7	16.09	0.00	6.62	1.89	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	13.67	3.47	7.14	0.82	2.86	1.02
hippocampus, adult, donor10258	10374-105G5	13.94	0.50	9.46	1.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	24.32	1.06	0.35	2.82	2.11	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	19.53	3.05	1.22	3.66	1.22	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	23.76	3.34	0.59	6.68	1.18	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	20.57	1.02	1.52	5.84	2.03	3.30
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.58	1.69	2.26	8.46	1.69	11.28
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	20.66	4.39	0.77	13.43	3.36	11.36
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	22.78	2.28	2.28	10.25	3.04	7.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	14.31	2.34	0.29	3.80	2.92	7.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	11.42	1.08	0.65	11.20	3.45	7.54
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	15.85	1.25	0.83	6.26	2.09	7.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	12.08	2.84	1.18	3.08	2.84	3.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	16.39	2.57	1.45	7.39	2.41	5.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	16.16	0.67	1.35	6.73	1.35	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	18.15	2.82	0.47	3.13	1.72	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	11.79	1.47	1.97	2.95	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	7.85	0.87	0.00	2.62	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	31.69	3.25	1.15	7.64	3.25	8.40
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	28.78	3.05	1.31	5.67	1.74	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	42.48	4.50	2.00	5.00	2.00	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	14.88	1.51	1.13	3.77	1.32	3.20
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.64	0.91	1.82	1.36	0.00	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	17.23	2.51	0.31	3.45	1.25	4.07
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	14.04	3.10	1.63	3.43	1.31	3.59
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.58	4.06	2.03	2.03	1.74	2.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	22.72	3.59	1.20	4.18	2.69	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	23.65	2.77	1.11	9.98	2.22	5.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	22.25	2.28	1.14	9.41	0.57	4.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	17.97	0.82	1.22	6.53	2.45	4.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	25.70	3.52	1.06	8.10	3.87	7.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.29	5.07	1.58	12.67	4.12	6.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.63	3.93	2.12	12.41	1.82	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	17.58	6.72	0.52	7.76	1.03	6.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.94	2.66	0.66	9.30	3.98	3.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	14.37	1.54	1.03	7.70	2.05	4.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	11.25	3.07	1.79	3.32	2.30	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	15.14	1.51	1.51	7.57	6.82	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	13.44	3.02	2.35	4.70	1.68	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	24.63	4.11	0.72	8.94	3.62	9.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	33.42	1.34	1.34	5.35	2.23	7.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	29.27	3.90	0.49	9.76	1.95	6.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	28.42	2.75	1.22	8.86	1.53	10.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	17.21	3.31	0.99	2.65	2.65	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	16.42	4.38	1.64	6.57	0.00	10.40
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	15.56	0.72	1.81	4.70	1.45	6.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	13.88	1.07	1.42	4.98	2.49	5.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	0.00	0.00	4.77	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	13.27	1.76	1.08	5.96	2.98	3.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	13.74	2.42	1.35	4.85	1.89	4.31
immature langerhans cells, donor1	11904-125F5	0.24	0.73	1.21	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	0.00	0.79	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	22.62	3.50	9.65	1.61	2.46	1.23
keratoacanthoma cell line:HKA-1	10791-110H8	16.26	12.03	4.88	4.88	1.63	1.95
kidney, adult, pool1	10017-101C8	10.81	3.30	4.41	0.90	2.40	0.50
kidney, fetal, pool1	10045-101F9	9.05	2.33	3.04	0.99	1.27	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	16.05	4.12	3.83	6.96	2.27	6.11
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.33	3.18	1.94	0.28	0.69	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	21.29	5.87	2.39	1.28	0.37	1.47
left atrium, adult, donor1	10079-102A7	8.17	2.18	4.36	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	2.02	0.51	4.05	1.52	2.02	1.01
leiomyoblastoma cell line:G-402	10721-110A1	11.77	7.93	1.92	1.92	0.82	3.01
leiomyoma cell line:10964C	10569-108B2	14.37	1.80	2.51	0.72	0.36	1.44
leiomyoma cell line:15242A	10570-108B3	6.52	0.54	2.72	1.09	1.09	0.00
leiomyoma cell line:15425	10571-108B4	12.14	3.16	4.37	0.73	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	10.46	3.14	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	16.65	8.38	2.36	5.78	2.60	5.19
liposarcoma cell line:KMLS-1	10782-110G8	12.18	3.75	1.41	0.62	0.78	0.16
liposarcoma cell line:SW 872	10726-110A6	12.67	4.14	4.51	3.41	1.34	0.85
liver, adult, pool1	10018-101C9	12.64	3.40	4.21	1.13	0.97	0.32
liver, fetal, pool1	10086-102B5	5.64	1.88	1.88	1.88	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	6.71	1.90	4.37	0.87	2.04	0.44
locus coeruleus, adult, donor10252	10165-103B3	8.49	1.85	3.14	0.92	0.92	0.18
locus coeruleus, adult, donor10258	10375-105G6	5.92	1.41	7.34	1.41	0.85	0.28
locus coeruleus, newborn, donor10223	10362-105F2	7.99	0.84	0.42	0.42	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	6.09	2.35	1.11	1.52	0.97	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	31.71	4.14	1.38	2.07	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	5.93	4.48	3.43	0.92	0.53	0.79
lung, adult, pool1	10019-101D1	9.69	1.65	3.43	0.83	1.18	0.12
lung, fetal, donor1	10068-101I5	4.85	0.57	0.29	0.86	1.71	0.29
lung, right lower lobe, adult, donor1	10075-102A3	10.54	8.71	6.42	1.83	2.75	0.46
lymph node, adult, donor1	10077-102A5	6.63	4.26	4.26	3.31	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	9.21	4.38	3.07	1.53	0.88	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	4.83	1.81	0.60	1.06	0.30	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	8.49	0.00	4.25	2.55	2.55	0.85
mature adipocyte, donor1	12231-129F8	6.22	3.11	4.00	0.89	3.11	0.00
mature adipocyte, donor2	12232-129F9	5.19	1.66	4.77	0.00	1.87	0.00
mature adipocyte, donor3	12233-129G1	3.56	2.37	5.69	0.71	0.71	0.00
mature adipocyte, donor4	12234-129G2	3.42	1.32	4.21	0.26	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	26.69	8.58	5.24	3.34	1.91	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	14.66	0.00	6.77	2.26	2.26	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	14.16	2.76	8.64	0.92	2.21	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	15.88	2.54	9.85	1.91	1.91	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	8.96	1.28	0.43	0.43	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	18.39	1.86	9.45	1.86	2.53	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	16.13	2.76	9.55	0.64	3.40	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	1.93	3.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	25.48	0.72	5.74	1.08	0.00	1.08
medulla oblongata - adult, donor10196	10174-103C3	3.89	1.30	3.24	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	9.60	1.70	3.41	0.15	1.55	0.31
medulla oblongata, adult, pool1	10038-101F2	8.16	1.47	4.41	0.82	2.37	0.24
medulla oblongata, newborn, donor10223	10361-105F1	12.15	2.08	3.12	0.35	2.08	1.04
medulloblastoma cell line:D283 Med	10838-111E1	14.83	3.76	2.66	4.65	2.44	2.88
medulloblastoma cell line:ONS-76	10759-110E3	6.73	3.91	3.67	2.08	1.59	0.98
melanoma cell line:COLO 679	10514-107E1	6.47	3.88	7.19	1.72	2.73	1.01
melanoma cell line:G-361	10465-106H6	10.32	5.97	6.52	2.99	3.53	1.09
meningioma cell line:HKBMM	10691-109F7	5.97	1.99	2.89	0.36	0.54	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	23.79	7.93	2.64	7.05	1.76	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	30.33	5.70	1.04	2.59	0.78	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	7.98	2.45	2.92	0.77	0.46	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	5.45	1.09	2.00	0.55	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	18.63	1.24	0.41	0.00	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	6.88	1.55	1.12	0.42	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.86	1.16	1.54	0.19	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	2.08	0.69	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	12.19	3.43	1.20	0.17	1.03	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	12.77	3.91	1.96	0.23	1.04	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	7.43	1.86	2.79	0.13	0.40	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	8.37	3.38	1.89	0.41	0.14	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	9.39	2.85	1.14	0.43	0.57	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.89	2.31	1.65	0.33	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	8.86	2.35	1.52	0.14	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	12.22	1.05	2.44	0.35	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.15	0.82	1.22	0.20	0.00	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.99	1.08	1.08	0.72	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.83	1.55	1.55	0.00	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.03	2.74	2.51	0.00	0.91	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	5.45	0.42	2.10	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	9.41	1.34	0.90	0.15	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	9.72	2.71	1.14	0.44	0.44	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.52	2.95	3.31	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	9.44	1.72	1.72	0.57	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	6.32	2.53	2.11	0.00	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.50	2.28	3.20	0.00	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.30	3.33	2.56	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	13.35	2.88	1.31	0.26	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.10	3.08	1.85	0.92	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.77	2.59	2.82	1.41	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	12.86	1.35	2.71	0.68	1.02	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.58	2.36	4.32	0.39	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.68	2.32	2.78	0.46	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.71	4.33	4.04	0.58	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	14.06	2.45	2.90	0.67	0.22	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.26	4.09	1.44	0.00	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	9.53	4.40	3.67	0.73	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.77	3.36	2.69	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	16.38	3.28	1.64	0.82	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	11.17	2.15	0.43	0.86	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	11.04	3.90	3.25	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	1.45	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	8.00	3.73	2.67	1.07	2.13	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	4.09	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	11.27	1.94	3.11	0.39	1.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	2.10	2.10	0.00	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	0.99	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.27	1.78	1.19	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	3.66	0.00	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.13	3.17	3.17	0.00	1.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.90	1.72	2.76	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	0.00	2.15	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.96	3.67	2.04	0.00	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	2.38	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.97	3.54	5.90	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	11.84	3.12	4.05	0.62	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	4.01	2.67	1.34	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	3.55	4.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	16.52	2.07	4.13	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	5.44	3.96	4.45	0.00	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	3.36	4.49	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.00	3.18	3.18	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	19.34	8.06	3.22	1.61	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	2.18	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	20.27	7.60	2.53	3.80	2.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	14.57	3.64	1.82	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	9.04	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	16.47	11.53	1.65	0.82	2.47	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.92	1.98	2.18	0.20	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.11	4.22	1.30	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	8.15	2.04	2.04	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	7.74	4.64	0.77	0.77	1.55	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	14.17	3.54	2.36	0.24	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	4.63	2.09	0.23	0.93	0.70	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	4.27	4.27	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	12.64	6.68	6.88	0.51	1.44	0.51
mesothelioma cell line:Mero-25	10850-111F4	14.07	6.35	2.95	3.86	1.59	2.50
mesothelioma cell line:Mero-41	10851-111F5	24.69	5.87	6.36	1.71	0.49	0.73
mesothelioma cell line:Mero-48a	10852-111F6	11.74	3.54	3.54	1.33	0.44	1.33
mesothelioma cell line:Mero-82	10853-111F7	5.52	3.68	3.15	2.63	1.05	1.05
mesothelioma cell line:Mero-83	10854-111F8	14.81	6.13	3.40	1.87	1.53	1.70
mesothelioma cell line:Mero-84	10855-111F9	9.86	6.32	3.79	0.51	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	8.28	2.90	4.76	1.45	1.04	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	9.77	3.98	6.96	0.99	1.99	0.50
mesothelioma cell line:NCI-H226	10846-111E9	6.33	2.71	1.99	1.63	0.54	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	13.67	3.42	2.22	1.37	1.02	0.68
mesothelioma cell line:NCI-H28	10845-111E8	21.63	7.63	1.02	3.05	0.51	1.27
mesothelioma cell line:No36	10857-111G2	15.33	3.91	1.96	0.65	0.98	0.98
mesothelioma cell line:ONE58	10858-111G3	18.15	5.15	3.25	1.63	0.81	0.81
migratory langerhans cells, donor1	11901-125F2	0.96	0.38	0.58	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	4.15	0.73	1.83	0.12	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	2.51	0.18	1.08	0.54	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	10.77	3.26	0.33	0.33	0.65	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	3.18	3.18	2.54	0.64	0.42	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	13.36	8.29	3.69	2.76	0.23	2.07
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.42	4.00	2.85	0.76	0.95	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	10.16	8.13	2.77	1.66	1.29	2.03
myeloma cell line:PCM6	10474-106I6	11.66	6.92	6.72	2.17	3.16	1.58
myxofibrosarcoma cell line:MFH-ino	10600-108E6	8.62	2.54	2.03	0.51	1.01	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	10.20	4.71	7.65	0.59	1.18	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	16.16	3.34	0.56	0.00	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	14.05	2.72	0.44	0.00	0.44	0.37
nasal epithelial cells, donor2	12227-129F4	7.73	5.52	2.21	0.55	0.55	1.10
neuroblastoma cell line:CHP-134	10508-107D4	5.29	0.23	1.84	12.65	6.21	4.14
neuroblastoma cell line:NB-1	10539-107G8	13.84	1.68	1.12	1.12	1.68	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	15.61	7.59	2.95	0.42	1.05	0.63
neuroblastoma cell line:NH-12	10555-107I6	14.16	5.22	2.42	1.30	3.35	2.05
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	8.07	1.42	2.14	0.71	1.19	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	16.31	4.75	2.06	1.58	0.00	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	9.86	3.62	0.81	2.01	1.01	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	35.60	10.81	3.18	3.18	0.64	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	8.78	6.92	5.86	1.06	1.33	1.60
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.68	0.34	0.00	1.35	0.00	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	3.20	0.00	1.60	0.80	0.80	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	5.13	3.53	0.96	0.32	1.28	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	5.52	1.84	1.84	0.26	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	17.25	2.44	6.37	1.12	3.37	1.03
occipital cortex - adult, donor10196	10172-103C1	16.48	2.06	10.30	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	17.44	4.56	10.47	1.34	1.88	0.00
occipital cortex, newborn, donor10223	10355-105E4	29.48	2.55	1.82	0.36	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	18.37	6.04	12.86	2.36	2.89	2.10
occipital lobe, fetal, donor1	10073-102A1	14.59	2.15	4.72	1.72	1.72	0.00
occipital pole, adult, pool1	10036-101E9	20.10	3.23	13.17	2.13	3.47	0.95
olfactory region, adult	10195-103E6	14.14	2.67	4.78	0.76	1.53	0.57
optic nerve, donor1	10277-104E7	2.00	2.00	6.00	2.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	56.16	21.41	2.73	6.38	0.68	3.42
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	17.17	5.77	1.24	1.79	0.41	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	25.06	6.43	2.71	2.03	1.69	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	21.60	11.09	3.47	3.47	1.16	1.96
osteoclastoma cell line:Hs 706.T	10704-109H2	14.70	3.82	5.59	0.59	1.18	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	7.47	1.87	3.74	1.87	6.54	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	8.91	2.97	0.85	0.85	0.42	1.06
ovary, adult, pool1	10020-101D2	13.98	3.32	5.59	1.31	0.96	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.42	2.93	0.92	1.10	0.18	0.00
pancreas, adult, donor1	10049-101G4	7.53	2.82	4.70	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.69	7.27	1.96	4.47	1.68	3.35
papillary adenocarcinoma cell line:8505C	10437-106E5	13.80	3.58	1.70	1.02	1.87	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	13.41	4.47	4.31	1.66	1.32	0.33
paracentral gyrus, adult, pool1	10035-101E8	19.22	3.20	10.71	1.92	3.75	0.64
parietal cortex, adult, donor10258	10373-105G4	15.41	0.73	1.47	1.47	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	12.23	3.76	2.82	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	13.68	2.00	7.13	0.57	4.28	0.57
parietal lobe, adult, pool1	10034-101E7	16.57	2.64	7.84	0.88	2.56	0.62
parietal lobe, fetal, donor1	10072-101I9	19.40	0.97	4.85	2.91	1.94	1.94
parietal lobe, newborn, donor10223	10356-105E5	25.80	0.75	4.11	0.75	0.75	1.12
parotid gland, adult	10199-103F1	8.63	2.47	7.40	1.23	1.23	0.00
penis, adult	10200-103F2	5.37	0.54	7.52	1.07	3.22	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2.97	0.56	1.49	0.19	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	9.03	3.79	2.04	2.62	1.17	2.33
pineal gland - adult, donor10196	10179-103C8	1.94	0.65	7.10	0.00	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	1.78	1.18	1.78	0.00	2.37	0.59
pineal gland, adult, donor10258	10377-105G8	1.88	0.00	2.51	1.25	1.25	1.25
pituitary gland - adult, donor10196	10180-103C9	5.06	2.02	3.04	0.00	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	6.78	2.61	2.61	0.52	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	5.11	0.00	1.70	1.70	2.55	0.00
placenta, adult, pool1	10021-101D3	13.76	3.33	3.87	1.08	1.18	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	8.48	3.31	1.72	2.25	1.06	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	6.85	2.49	2.33	0.31	0.31	0.16
pons, adult, pool1	10033-101E6	4.73	2.24	6.02	1.55	3.36	0.43
postcentral gyrus, adult, pool1	10032-101E5	19.00	2.88	9.41	1.48	3.05	0.78
promyelocytes/myelocytes PMC, donor1	12132-128D8	8.37	4.18	2.09	6.27	2.09	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	9.18	2.77	0.87	0.73	0.00	0.58
prostate cancer cell line:PC-3	10439-106E7	12.34	3.27	3.27	1.82	0.91	0.73
prostate, adult, pool1	10022-101D4	10.70	2.72	4.90	1.36	2.54	0.82
putamen, adult, donor10196	10176-103C5	23.84	3.30	5.43	3.30	2.60	0.71
putamen, adult, donor10252	10152-102I8	21.57	0.00	9.80	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	17.48	0.00	2.19	5.46	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	26.09	1.21	5.32	1.69	0.97	1.69
putamen, newborn, donor10223	10365-105F5	3.00	2.25	0.00	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	11.64	2.91	0.29	2.33	0.58	0.58
rectum, fetal, donor1	10067-101I4	1.39	4.17	2.78	2.78	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	5.72	1.48	1.70	0.00	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	6.21	2.07	0.83	0.41	0.41	0.00
retina, adult, pool1	10030-101E3	6.16	1.39	4.57	1.19	2.48	0.50
retinoblastoma cell line:Y79	10475-106I7	4.68	0.78	1.04	3.64	1.82	4.42
rhabdomyosarcoma cell line:KYM-1	10787-110H4	11.43	4.06	0.98	2.34	0.37	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	6.19	0.28	0.28	0.28	0.84	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	5.30	3.03	2.27	0.76	0.76	0.76
salivary acinar cells, donor1	11771-123I7	9.87	3.72	3.08	1.29	0.16	0.65
salivary acinar cells, donor2	11772-123I8	9.91	4.13	3.17	0.96	1.24	0.69
salivary acinar cells, donor3	11773-123I9	16.55	4.63	2.65	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	8.58	1.14	5.72	0.00	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	5.56	1.43	4.22	1.18	1.69	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	7.29	3.41	3.06	1.41	1.06	0.35
seminal vesicle, adult	10201-103F3	5.29	1.59	4.23	0.00	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	8.50	2.92	1.21	0.73	0.00	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	11.07	0.75	2.52	0.00	1.01	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	18.06	1.00	3.01	1.00	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	16.66	10.61	5.24	2.42	0.94	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	9.95	5.53	1.66	1.33	0.99	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	16.52	6.71	5.16	1.81	0.52	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	5.67	2.13	3.55	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	8.76	3.00	4.08	1.44	3.72	0.24
skeletal muscle, fetal, donor1	10066-101I3	9.05	3.02	2.01	3.02	2.01	3.02
skin, adult, donor1	10074-102A2	6.79	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	10.73	2.52	3.16	0.63	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	28.68	6.34	1.67	3.67	0.33	2.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	11.98	2.52	1.89	2.52	1.58	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.79	2.31	1.16	0.19	0.58	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	11.21	2.97	0.66	0.99	0.33	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	4.18	0.32	0.00	1.13	0.48	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	3.92	1.31	4.14	3.05	5.23	1.96
small intestine, adult, pool1	10024-101D6	20.42	7.05	6.93	1.31	1.31	0.36
small intestine, fetal, donor1	10064-101I1	17.20	9.34	4.67	1.72	1.47	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.39	5.64	4.10	0.51	1.54	0.51
smooth muscle, adult, pool1	10048-101G3	6.46	2.07	7.75	0.78	2.58	0.78
somatostatinoma cell line:QGP-1	10781-110G7	21.44	11.52	2.14	1.61	0.00	3.48
spinal cord - adult, donor10196	10181-103D1	6.65	1.38	2.29	2.06	3.21	0.69
spinal cord, adult, donor10252	10159-103A6	7.89	1.97	1.18	0.00	1.58	0.39
spinal cord, adult, donor10258	10369-105F9	4.84	1.38	2.08	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	9.76	2.44	5.49	1.83	3.05	0.00
spinal cord, newborn, donor10223	10359-105E8	15.15	3.67	1.84	0.00	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	19.71	5.97	2.69	0.75	0.90	0.90
spleen, adult, pool1	10025-101D7	9.03	3.85	3.85	2.20	2.09	0.55
spleen, fetal, pool1	10044-101F8	7.79	1.83	3.34	0.95	1.03	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	3.62	1.97	1.04	0.52	0.31	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	23.92	8.35	2.47	1.90	0.95	3.04
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	8.39	3.84	1.75	0.70	2.45	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	9.38	3.13	2.35	3.52	0.00	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	5.29	2.25	3.60	5.29	2.36	3.71
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	8.90	1.69	2.12	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	14.81	2.54	2.12	1.27	0.85	2.12
stomach, fetal, donor1	10062-101H8	7.48	3.20	1.07	1.07	2.14	1.07
submaxillary gland, adult	10202-103F4	13.67	2.28	5.70	0.57	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	6.65	1.87	3.32	0.62	1.04	0.00
substantia nigra, adult, donor10258	10371-105G2	7.24	0.52	2.07	1.55	3.62	0.52
substantia nigra, newborn, donor10223	10358-105E7	16.25	0.71	2.83	1.41	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	10.55	4.13	6.19	1.60	2.29	0.00
temporal lobe, adult, pool1	10031-101E4	25.60	3.56	10.51	1.10	4.41	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	14.25	0.00	4.27	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	11.43	1.76	3.52	0.88	2.20	0.00
tenocyte, donor1	11763-123H8	18.85	6.28	3.84	0.70	0.70	0.70
tenocyte, donor2	11765-123I1	13.73	2.29	4.58	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	10.01	2.97	3.34	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	14.96	2.72	0.68	3.57	1.19	1.87
teratocarcinoma cell line:NCR-G1	10798-110I6	14.03	7.71	2.00	6.32	1.85	4.47
teratocarcinoma cell line:PA-1	10807-111A6	13.48	3.25	1.24	4.34	2.17	3.25
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	24.63	12.57	1.90	4.19	1.65	2.54
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	13.24	5.29	0.76	3.03	1.13	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	16.47	4.36	0.11	1.96	0.65	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	5.86	1.30	0.00	3.58	0.33	0.98
testis, adult, pool1	10026-101D8	14.92	3.22	5.48	1.61	5.91	0.43
testis, adult, pool2	10096-102C6	15.79	1.35	3.61	4.06	9.02	1.35
thalamus - adult, donor10196	10168-103B6	6.62	2.21	3.31	2.21	2.21	0.00
thalamus, adult, donor10252	10154-103A1	13.28	2.34	4.53	0.31	1.56	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	0.00	3.08	9.24	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.22	1.65	4.12	1.65	2.96	1.15
thalamus, newborn, donor10223	10366-105F6	10.36	1.73	1.15	0.00	0.00	0.00
throat, adult	10209-103G2	6.74	2.75	4.24	1.00	2.25	0.25
throat, fetal, donor1	10061-101H7	7.31	3.96	1.83	0.00	2.44	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	5.96	2.58	10.73	3.97	1.39	1.39
thymus, adult, pool1	10027-101D9	15.31	2.58	2.98	3.88	1.19	1.69
thymus, fetal, pool1	10043-101F7	10.39	2.70	0.83	1.66	1.77	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	7.84	1.46	3.86	0.93	0.93	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	8.52	4.33	4.47	2.79	1.12	2.37
thyroid, adult, pool1	10028-101E1	10.82	2.33	4.67	1.12	1.96	0.56
thyroid, fetal, donor1	10060-101H6	7.38	1.58	1.32	0.26	1.05	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	6.16	6.16	0.00	6.16	0.00
tongue, adult	10203-103F5	7.91	3.72	4.42	0.47	2.33	0.23
tongue, fetal, donor1	10059-101H5	6.70	4.34	3.94	0.00	3.15	0.00
tonsil, adult, pool1	10047-101G2	11.02	2.40	6.21	1.80	2.40	0.70
trachea, adult, pool1	10029-101E2	9.65	3.11	4.17	0.82	0.57	0.41
trachea, fetal, donor1	10058-101H4	8.08	1.92	3.08	1.54	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	9.57	4.61	6.73	1.42	0.35	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	16.41	5.88	1.01	0.71	1.22	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	20.37	3.92	1.57	0.78	0.16	1.10
tridermal teratoma cell line:HGRT	10694-109G1	17.12	0.00	0.00	0.00	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.28	6.77	2.37	2.20	0.93	1.10
umbilical cord, fetal, donor1	10057-101H3	10.43	4.17	4.17	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	6.65	1.88	2.73	1.02	2.05	0.00
uterus, fetal, donor1	10055-101H1	7.17	3.07	1.02	0.51	0.51	0.51
vagina, adult	10204-103F6	10.99	2.58	2.58	0.65	0.65	0.00
vein, adult	10191-103E2	6.14	2.63	3.95	1.32	2.19	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4.01	1.87	0.53	1.60	0.27	0.27